{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:35:34Z","timestamp":1790858134168,"version":"4.1.0"},"reference-count":264,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T00:00:00Z","timestamp":1711584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T00:00:00Z","timestamp":1711584000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001602","name":"Science Foundation Ireland","doi-asserted-by":"crossref","award":["SFI\/12\/RC\/2273_P2"],"award-info":[{"award-number":["SFI\/12\/RC\/2273_P2"]}],"id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001602","name":"Science Foundation Ireland","doi-asserted-by":"crossref","award":["SFI\/12\/RC\/2273_P2"],"award-info":[{"award-number":["SFI\/12\/RC\/2273_P2"]}],"id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001602","name":"Science Foundation Ireland","doi-asserted-by":"crossref","award":["SFI\/12\/RC\/2273_P2"],"award-info":[{"award-number":["SFI\/12\/RC\/2273_P2"]}],"id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001602","name":"Science Foundation Ireland","doi-asserted-by":"crossref","award":["SFI\/12\/RC\/2273_P2"],"award-info":[{"award-number":["SFI\/12\/RC\/2273_P2"]}],"id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100019180","name":"HORIZON EUROPE European Research Council","doi-asserted-by":"publisher","award":["ERC, BACtheWINNER, Project No. 101054719"],"award-info":[{"award-number":["ERC, BACtheWINNER, Project No. 101054719"]}],"id":[{"id":"10.13039\/100019180","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Vancomycin-resistant enterococci (VRE) are major opportunistic pathogens and the causative agents of serious diseases, such as urinary tract infections and endocarditis. VRE strains mainly include species of <jats:italic>Enterococcus faecium<\/jats:italic> and <jats:italic>E. faecalis<\/jats:italic> which can colonise the gastrointestinal tract (GIT) of patients and, following growth and persistence in the gut, can transfer to blood resulting in systemic dissemination in the body. Advancements in genomics have revealed that hospital-associated VRE strains are characterised by increased numbers of mobile genetic elements, higher numbers of antibiotic resistance genes and often lack active CRISPR-Cas systems. Additionally, comparative genomics have increased our understanding of dissemination routes among patients and healthcare workers. Since the efficiency of currently available antibiotics is rapidly declining, new measures to control infection and dissemination of these persistent pathogens are urgently needed. These approaches include combinatory administration of antibiotics, strengthening colonisation resistance of the gut microbiota to reduce VRE proliferation through commensals or probiotic bacteria, or switching to non-antibiotic bacterial killers, such as bacteriophages or bacteriocins. In this review, we discuss the current knowledge of the genomics of VRE isolates and state-of-the-art therapeutic advances against VRE infections.<\/jats:p>","DOI":"10.1186\/s12866-024-03243-2","type":"journal-article","created":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T01:30:42Z","timestamp":1711589442000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Promiscuous, persistent and problematic: insights into current enterococcal genomics to guide therapeutic strategy"],"prefix":"10.1186","volume":"24","author":[{"given":"David","family":"Hourigan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewelina","family":"Stefanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Paul","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,28]]},"reference":[{"key":"3243_CR1","volume-title":"The enterococcus: A model of adaptability to its environment","author":"M Garc\u00eda-Solache","year":"2019","unstructured":"Garc\u00eda-Solache M, Rice LB. The enterococcus: A model of adaptability to its environment, vol. 32. Clinical Microbiology Reviews: American Society for Microbiology; 2019."},{"key":"3243_CR2","doi-asserted-by":"publisher","unstructured":"Ahmed MO, Baptiste KE. Vancomycin-resistant enterococci: A review of antimicrobial resistance mechanisms and perspectives of human and animal health. Microb Drug Resist. 2018;24(5):590\u2013606. https:\/\/doi.org\/10.1089\/mdr.2017.0147.","DOI":"10.1089\/mdr.2017.0147"},{"key":"3243_CR3","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.jgar.2014.04.002","volume":"2","author":"S Ranotkar","year":"2014","unstructured":"Ranotkar S, Kumar P, Zutshi S, Prashanth KS, Bezbaruah B, Anand J, et al. Vancomycin-resistant enterococci: Troublemaker of the 21st century. J Global Antimicrob Resist. 2014;2:205\u201312 Elsevier Ltd.","journal-title":"J Global Antimicrob Resist"},{"issue":"5","key":"3243_CR4","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.cell.2017.04.027","volume":"169","author":"F Lebreton","year":"2017","unstructured":"Lebreton F, Manson AL, Saavedra JT, Straub TJ, Earl AM, Gilmore MS. Tracing the enterococci from paleozoic origins to the hospital. Cell. 2017;169(5):849\u2013861.e13.","journal-title":"Cell"},{"issue":"4","key":"3243_CR5","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1046\/j.1525-1381.1999.99241.x","volume":"111","author":"BE Murray","year":"1999","unstructured":"Murray BE, Weinstock GM. Enterococci: new aspects of an old organism. Proc Assoc Am Physicians. 1999;111(4):328\u201334.","journal-title":"Proc Assoc Am Physicians"},{"key":"3243_CR6","unstructured":"DSMZ. Genus: Enterococcus. 2023. Available from: https:\/\/lpsn.dsmz.de\/genus\/enterococcus. Cited 2023 Jun 1."},{"issue":"196","key":"3243_CR7","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.micres.2016.12.009","volume":"1","author":"Z Zhong","year":"2017","unstructured":"Zhong Z, Zhang W, Song Y, Liu W, Xu H, Xi X, et al. Comparative genomic analysis of the genus Enterococcus. Microbiol Res. 2017;1(196):95\u2013105.","journal-title":"Microbiol Res"},{"issue":"6","key":"3243_CR8","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1084\/jem.4.5-6.521","volume":"5","author":"WG MacCallum","year":"1899","unstructured":"MacCallum WG, Hastings TW. A case of acute endocarditis caused by micrococcus zymogenes (nov. Spec.), witi-i a description of the microorganis. J Exp Med. 1899;5(6):521\u201334.","journal-title":"J Exp Med"},{"key":"3243_CR9","doi-asserted-by":"crossref","unstructured":"Arredondo-Alonso S, Top J, McNally A, Puranen S, Pesonen M, Pensar J, et al. Plasmids shaped the recent emergence of the major nosocomial pathogen Enterococcus faecium. mBio. 2020;11(1). Available from: https:\/\/microreact.org\/project\/BJKGTJPTQ. Cited 2022 Aug 16.","DOI":"10.1128\/mBio.03284-19"},{"issue":"1","key":"3243_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-021-21749-5","volume":"12","author":"AK P\u00f6ntinen","year":"2021","unstructured":"P\u00f6ntinen AK, Top J, Arredondo-Alonso S, Tonkin-Hill G, Freitas AR, Novais C, et al. Apparent nosocomial adaptation of Enterococcus faecalis predates the modern hospital era. Nat Commun. 2021;12(1):1\u201313. Available from: https:\/\/www.nature.com\/articles\/s41467-021-21749-5. Cited 2023 Oct 4.","journal-title":"Nat Commun"},{"issue":"4","key":"3243_CR11","doi-asserted-by":"publisher","first-page":"e00534","DOI":"10.1128\/mBio.00534-13","volume":"4","author":"F Lebreton","year":"2013","unstructured":"Lebreton F, van Schaik W, McGuire AM, Godfrey P, Griggs A, Mazumdar V, et al. Emergence of epidemic multidrug-resistant Enterococcus faecium from animal and commensal strains. mBio. 2013;4(4):e00534\u201313.","journal-title":"mBio"},{"key":"3243_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijfoodmicro.2005.06.026","volume":"106","author":"MR Foulqui\u00e9 Moreno","year":"2006","unstructured":"Foulqui\u00e9 Moreno MR, Sarantinopoulos P, Tsakalidou E, de Vuyst L. The role and application of enterococci in food and health. Int J Food Microbiol. 2006;106:1\u201324.","journal-title":"Int J Food Microbiol"},{"key":"3243_CR13","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.ijfoodmicro.2011.08.014","volume":"151","author":"CMAP Franz","year":"2011","unstructured":"Franz CMAP, Huch M, Abriouel H, Holzapfel W, G\u00e1lvez A. Enterococci as probiotics and their implications in food safety. Int J Food Microbiol. 2011;151:125\u201340.","journal-title":"Int J Food Microbiol."},{"issue":"2\u20133","key":"3243_CR14","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0168-1605(03)00175-2","volume":"88","author":"G Klein","year":"2003","unstructured":"Klein G. Taxonomy, ecology and antibiotic resistance of enterococci from food and the gastro-intestinal tract. Int J Food Microbiol. 2003;88(2\u20133):123\u201331.","journal-title":"Int J Food Microbiol"},{"issue":"269","key":"3243_CR15","first-page":"269","volume":"50","author":"M Thiercelin","year":"1899","unstructured":"Thiercelin M. Sur ur diplocoque saprophyte de l\u2019intesti susceptible de devenir pathogene. C R Seabces Soc Biol. 1899;50(269):269\u201371.","journal-title":"C R Seabces Soc Biol"},{"issue":"7937","key":"3243_CR16","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1038\/s41586-022-05438-x","volume":"611","author":"AB Smith","year":"2022","unstructured":"Smith AB, Jenior ML, Keenan O, Hart JL, Specker J, Abbas A, et al. Enterococci enhance Clostridioides difficile pathogenesis. Nature. 2022;611(7937):780\u20136. Available from: https:\/\/www.nature.com\/articles\/s41586-022-05438-x. Cited 2022 Nov 30.","journal-title":"Nature"},{"issue":"1","key":"3243_CR17","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13073-021-00868-0","volume":"13","author":"SJ van Hal","year":"2021","unstructured":"van Hal SJ, Willems RJL, Gouliouris T, Ballard SA, Coque TM, Hammerum AM, et al. The global dissemination of hospital clones of Enterococcus faecium. Genome Med. 2021;13(1):52.","journal-title":"Genome Med"},{"issue":"12","key":"3243_CR18","doi-asserted-by":"publisher","first-page":"e3000987","DOI":"10.1371\/journal.pbio.3000987","volume":"18","author":"CL Kinnear","year":"2020","unstructured":"Kinnear CL, Hansen E, Morley VJ, Tracy KC, Forstchen M, Read AF, et al. Daptomycin treatment impacts resistance in off-target populations of vancomycin-resistant Enterococcus faecium. PLoS Biol. 2020;18(12):e3000987.","journal-title":"PLoS Biol"},{"key":"3243_CR19","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.nmni.2015.11.006","volume":"9","author":"SH Egido","year":"2016","unstructured":"Egido SH, Ruiz MS, In\u00e9s Revuelta S, Garc\u00eda IG, Bellido JLM. Enterococcus faecium small colony variant endocarditis in an immunocompetent patient. New Microbes New Infect. 2016;9:47\u20139 Elsevier Ltd.","journal-title":"New Microbes New Infect"},{"issue":"1","key":"3243_CR20","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ijmm.2011.07.001","volume":"302","author":"S Gr\u00f6bner","year":"2012","unstructured":"Gr\u00f6bner S, Beck J, Schaller M, Autenrieth IB, Schulte B. Characterization of an Enterococcus faecium small-colony variant isolated from blood culture. Int J Med Microbiol. 2012;302(1):40\u20134.","journal-title":"Int J Med Microbiol"},{"key":"3243_CR21","doi-asserted-by":"publisher","first-page":"421","DOI":"10.4161\/viru.21282","volume":"3","author":"BL Hollenbeck","year":"2012","unstructured":"Hollenbeck BL, Rice LB. Intrinsic and acquired resistance mechanisms in enterococcus. Virulence. 2012;3:421\u2013569 Taylor and Francis Inc.","journal-title":"Virulence"},{"key":"3243_CR22","first-page":"217","volume":"8","author":"T O\u2019Driscoll","year":"2015","unstructured":"O\u2019Driscoll T, Crank CW. Vancomycin-resistant enterococcal infections: epidemiology, clinical manifestations, and optimal management. Infect Drug Resist. 2015;8:217\u201330. Available from: https:\/\/www.dovepress.com\/vancomycin-resistant-enterococcal-infections-epidemiology-clinical-man-peer-reviewed-fulltext-article-IDR. Cited 2023 Aug 1.","journal-title":"Infect Drug Resist"},{"issue":"1","key":"3243_CR23","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13073-020-00825-3","volume":"13","author":"S Arredondo-Alonso","year":"2021","unstructured":"Arredondo-Alonso S, Top J, Corander J, Willems RJL, Sch\u00fcrch AC. Mode and dynamics of vanA-type vancomycin resistance dissemination in Dutch hospitals. Genome Med. 2021;13(1):9.","journal-title":"Genome Med"},{"key":"3243_CR24","doi-asserted-by":"crossref","unstructured":"Barna JC, Williams DH. The structure and mode of action of glycopeptide antibiotics of the vancomycin group. 1984;38:339\u201357. Available from: https:\/\/www.annualreviews.org\/doi\/abs\/10.1146\/annurev.mi.38.100184.00201110.1146\/annurev.mi38100184002011. Cited 2023 May 8.","DOI":"10.1146\/annurev.micro.38.1.339"},{"key":"3243_CR25","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3389\/fpubh.2014.00217","volume":"2","author":"E Rubinstein","year":"2014","unstructured":"Rubinstein E, Keynan Y. Vancomycin revisited - 60 years later. Front Public Health. 2014;2:217. Frontiers Media S.","journal-title":"Front Public Health"},{"issue":"8575\u20138576","key":"3243_CR26","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0140-6736(88)91037-9","volume":"331","author":"AHC Uttley","year":"1988","unstructured":"Uttley AHC, Collins CH, Naidoo J, George RC. Vancomycin-resistant enterococci. Lancet. 1988;331(8575\u20138576):57\u20138.","journal-title":"Lancet"},{"key":"3243_CR27","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s13756-020-00770-1","volume":"9","author":"X Zhou","year":"2020","unstructured":"Zhou X, Willems RJL, Friedrich AW, Rossen JWA, Bathoorn E. Enterococcus faecium: From microbiological insights to practical recommendations for infection control and diagnostics. Antimicrob Resist Infect Control. 2020;9:130. BioMed Central Ltd.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"7365","key":"3243_CR28","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nature10388","volume":"477","author":"VM Dcosta","year":"2011","unstructured":"Dcosta VM, King CE, Kalan L, Morar M, Sung WWL, Schwarz C, et al. Antibiotic resistance is ancient. Nature. 2011;477(7365):457\u201361. Available from: https:\/\/www.nature.com\/articles\/nature10388. Cited 2023 Jun 9.","journal-title":"Nature"},{"key":"3243_CR29","doi-asserted-by":"crossref","unstructured":"Perron GG, Whyte L, Turnbaugh PJ, Goordial J, Hanage WP, Dantas G, et al. Functional characterization of bacteria isolated from ancient arctic soil exposes diverse resistance mechanisms to modern antibiotics. PLoS One. 2015;10(3). Cited 2023 Jul 18.","DOI":"10.1371\/journal.pone.0069533"},{"issue":"10","key":"3243_CR30","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1093\/femsec\/fiaa172","volume":"96","author":"B Li","year":"2020","unstructured":"Li B, Chen Z, Zhang F, Liu Y, Yan T. Abundance, diversity and mobility potential of antibiotic resistance genes in pristine Tibetan Plateau soil as revealed by soil metagenomics. FEMS Microbiol Ecol. 2020;96(10):172. Available from: https:\/\/doi.org\/10.1093\/femsec\/fiaa172. Cited 2023 Jul 18.","journal-title":"FEMS Microbiol Ecol"},{"key":"3243_CR31","doi-asserted-by":"publisher","unstructured":"Brochu E, Huletsky A, Boudreau DK, Raymond F, Berube \u00c8, Ouameur AA, et al. Characterization of vancomycin-resistance vanD gene clusters in the human intestinal microbiota by metagenomics and culture-enriched metagenomics. JAC Antimicrob Resist. 2023;5(2). Available from: https:\/\/doi.org\/10.1093\/jacamr\/dlad026. Cited 2023 Jul 18.","DOI":"10.1093\/jacamr\/dlad026"},{"issue":"9259","key":"3243_CR32","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/S0140-6736(00)04206-9","volume":"357","author":"TP Stinear","year":"2001","unstructured":"Stinear TP, Olden DC, Johnson PDR, Davies JK, Grayson ML. Enterococcal vanB resistance locus in anaerobic bacteria in human faeces. The Lancet. 2001;357(9259):855\u20136.","journal-title":"The Lancet"},{"issue":"49","key":"3243_CR33","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.meegid.2016.12.029","volume":"1","author":"SY Lim","year":"2017","unstructured":"Lim SY, Yap KP, Teh CSJ, Jabar KA, Thong KL. Comparative genome analysis of multiple vancomycin-resistant Enterococcus faecium isolated from two fatal cases. Infect Genet Evol. 2017;1(49):55\u201365.","journal-title":"Infect Genet Evol"},{"issue":"5","key":"3243_CR34","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1111\/1751-7915.12139","volume":"7","author":"T Kruse","year":"2014","unstructured":"Kruse T, Levisson M, de Vos WM, Smidt H. vanI: A novel d-Ala-d-Lac vancomycin resistance gene cluster found in Desulfitobacterium hafniense. Microb Biotechnol. 2014;7(5):456\u201366.","journal-title":"Microb Biotechnol"},{"key":"3243_CR35","doi-asserted-by":"crossref","unstructured":"Park IS, Lin CH, Walsh CT, Bartlett PA, Ellsworth BA. Bacterial resistance to vancomycin: Overproduction, purification, and characterization of VanC2 from Enterococcus casseliflavus as a D-Ala-D-Ser ligase. Biochemistry. 1997;94. Available from: www.pnas.org.","DOI":"10.1073\/pnas.94.19.10040"},{"issue":"23","key":"3243_CR36","doi-asserted-by":"publisher","first-page":"6457","DOI":"10.1128\/JB.184.23.6457-6464.2002","volume":"184","author":"LA Pati\u00f1o","year":"2002","unstructured":"Pati\u00f1o LA, Courvalin P, Perichon B. vanE gene cluster of vancomycin-resistant Enterococcus faecalis BM4405. J Bacteriol. 2002;184(23):6457\u201364.","journal-title":"J Bacteriol"},{"issue":"12","key":"3243_CR37","doi-asserted-by":"publisher","first-page":"6389","DOI":"10.1128\/AAC.00747-12","volume":"56","author":"T Nomura","year":"2012","unstructured":"Nomura T, Tanimoto K, Shibayama K, Arakawa Y, Fujimoto S, Ike Y, et al. Identification of VanN-type vancomycin resistance in an Enterococcus faecium isolate from chicken meat in Japan. Antimicrob Agents Chemother. 2012;56(12):6389\u201392.","journal-title":"Antimicrob Agents Chemother"},{"issue":"36","key":"3243_CR38","doi-asserted-by":"publisher","first-page":"2100767","DOI":"10.2807\/1560-7917.ES.2021.26.36.2100767","volume":"26","author":"BB Xavier","year":"2021","unstructured":"Xavier BB, Coppens J, de Koster S, Rajakani SG, van Goethem S, Mzougui S, et al. Novel vancomycin resistance gene cluster in Enterococcus faecium ST1486, Belgium, June 2021. Eurosurveill. 2021;26(36):2100767.","journal-title":"Eurosurveill"},{"key":"3243_CR39","doi-asserted-by":"crossref","unstructured":"van Hal SJ, Ip CLC, Ansari MA, Wilson DJ, Espedido BA, Jensen SO, et al. Evolutionary dynamics of Enterococcus faecium reveals complex genomic relationships between isolates with independent emergence of vancomycin resistance. Microb Genom. 2016;2(1). Cited 2022 Aug 3.","DOI":"10.1099\/mgen.0.000048"},{"issue":"5","key":"3243_CR40","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.mib.2010.08.004","volume":"13","author":"KL Palmer","year":"2010","unstructured":"Palmer KL, Kos VN, Gilmore MS. Horizontal gene transfer and the genomics of enterococcal antibiotic resistance. Curr Opin Microbiol. 2010;13(5):632\u20139.","journal-title":"Curr Opin Microbiol"},{"issue":"1","key":"3243_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2105-5-113","volume":"5","author":"RC Edgar","year":"2004","unstructured":"Edgar RC. MUSCLE: A multiple sequence alignment method with reduced time and space complexity. BMC Bioinformatics. 2004;5(1):1\u201319. (Available from: https:\/\/bmcbioinformatics.biomedcentral.com\/articles\/10.1186\/1471-2105-5-113. Cited 2023 Aug 2.","journal-title":"BMC Bioinformatics"},{"issue":"21","key":"3243_CR42","doi-asserted-by":"publisher","first-page":"4453","DOI":"10.1093\/bioinformatics\/btz305","volume":"35","author":"AM Kozlov","year":"2019","unstructured":"Kozlov AM, Darriba D, Flouri T, Morel B, Stamatakis A. RAxML-NG: a fast, scalable and user-friendly tool for maximum likelihood phylogenetic inference. Bioinformatics. 2019;35(21):4453\u20135. Available from: https:\/\/doi.org\/10.1093\/bioinformatics\/btz305. Cited 2023 Aug 2.","journal-title":"Bioinformatics"},{"key":"3243_CR43","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1471-2180-12-135","volume":"12","author":"X Qin","year":"2012","unstructured":"Qin X, Galloway-P\u1ebda JR, Sillanpaa J, Roh JH, Nallapareddy SR, Chowdhury S, et al. Complete genome sequence of Enterococcus faecium strain TX16 and comparative genomic analysis of Enterococcus faecium genomes. BMC Microbiol. 2012;12:135.","journal-title":"BMC Microbiol"},{"issue":"23","key":"3243_CR44","doi-asserted-by":"publisher","first-page":"7273","DOI":"10.1073\/pnas.1500553112","volume":"112","author":"MS Gilmore","year":"2015","unstructured":"Gilmore MS, Rauch M, Ramsey MM, Himes PR, Varahan S, Manson JM, et al. Pheromone killing of multidrug-resistant Enterococcus faecalis V583 by native commensal strains. Proc Natl Acad Sci U S A. 2015;112(23):7273\u20138. Available from: https:\/\/www.pnas.org\/doi\/abs\/10.1073\/pnas.1500553112. Cited 2022 Aug 9.","journal-title":"Proc Natl Acad Sci U S A."},{"key":"3243_CR45","doi-asserted-by":"publisher","first-page":"788","DOI":"10.3389\/fmicb.2016.00788","volume":"7","author":"AM Guzman Prieto","year":"2016","unstructured":"Guzman Prieto AM, van Schaik W, Rogers MRC, Coque TM, Baquero F, Corander J, et al. Global emergence and dissemination of enterococci as nosocomial pathogens: Attack of the clones? Front Microbiol. 2016;7:788.","journal-title":"Front Microbiol"},{"issue":"2","key":"3243_CR46","doi-asserted-by":"publisher","first-page":"e02174","DOI":"10.1128\/AEM.02174-18","volume":"85","author":"W Huo","year":"2019","unstructured":"Huo W, Adams HM, Trejo C, Badia R, Palmer KL. A type I restriction-modification system associated with enterococcus faecium subspecies separation. Appl Environ Microbiol. 2019;85(2):e02174\u201318. Cited 2023 Oct 12.","journal-title":"Appl Environ Microbiol"},{"key":"3243_CR47","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.2217\/fmb.09.82","volume":"4","author":"RJL Willems","year":"2009","unstructured":"Willems RJL, van Schaik W. Transition of Enterococcus faecium from commensal organism to nosocomial pathogen. Future Microbiol. 2009;4:1125\u201335.","journal-title":"Future Microbiol"},{"key":"3243_CR48","doi-asserted-by":"publisher","unstructured":"Hendrickx APA, Van Schaik W, Willems RJL. The cell wall architecture of Enterococcus faecium: from resistance to pathogenesis. 2013;8(8):993\u20131010. Available from: https:\/\/doi.org\/10.2217\/fmb1366, https:\/\/www.futuremedicine.com\/doi\/10.2217\/fmb.13.66. Cited 2023 Oct 5.","DOI":"10.2217\/fmb1366"},{"issue":"2","key":"3243_CR49","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1128\/iai.45.2.528-530.1984","volume":"45","author":"Y Ike","year":"1984","unstructured":"Ike Y, Hashimoto H, Clewell DB. Hemolysin of Streptococcus faecalis subspecies zymogenes contributes to virulence in mice. Infect Immun. 1984;45(2):528\u201330. Available from: https:\/\/journals.asm.org\/doi\/10.1128\/iai.45.2.528-530.1984. Cited 2022 Aug 7.","journal-title":"Infect Immun"},{"issue":"4","key":"3243_CR50","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/nrmicro2761","volume":"10","author":"CA Arias","year":"2012","unstructured":"Arias CA, Murray BE. The rise of the Enterococcus: beyond vancomycin resistance. Nat Rev Microbiol. 2012;10(4):266\u201378. Available from: https:\/\/www.nature.com\/articles\/nrmicro2761. Cited 2022 Aug 7.","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"3243_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13104-020-05018-0","volume":"13","author":"A Kiruthiga","year":"2020","unstructured":"Kiruthiga A, Padmavathy K, Shabana P, Naveenkumar V, Gnanadesikan S, Malaiyan J. Improved detection of esp, hyl, asa1, gelE, cylA virulence genes among clinical isolates of Enterococci. BMC Res Notes. 2020;13(1):1\u20137. Available from: https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/s13104-020-05018-0. Cited 2023 Oct 5.","journal-title":"BMC Res Notes"},{"issue":"3","key":"3243_CR52","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1128\/IAI.73.3.1606-1612.2005","volume":"73","author":"J Zeng","year":"2005","unstructured":"Zeng J, Teng F, Murray BE. Gelatinase is important for translocation of Enterococcus faecalis across polarized human enterocyte-like T84 cells. Infect Immun. 2005;73(3):1606\u201312. Available from: https:\/\/journals.asm.org\/doi\/10.1128\/IAI.73.3.1606-1612.2005. Cited 2022 Aug 7.","journal-title":"Infect Immun"},{"issue":"5","key":"3243_CR53","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1590\/S0074-02762013000500009","volume":"108","author":"CB Comerlato","year":"2013","unstructured":"Comerlato CB, de Resende MCC, Caier\u00e3o J, d\u2019Azevedo PA. Presence of virulence factors in Enterococcus faecalis and Enterococcus faecium susceptible and resistant to vancomycin. Mem Inst Oswaldo Cruz. 2013;108(5):590. Cited 2022 Aug 7.","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"9","key":"3243_CR54","doi-asserted-by":"publisher","first-page":"6328","DOI":"10.4049\/jimmunol.181.9.6328","volume":"181","author":"SY Park","year":"2008","unstructured":"Park SY, Shin YP, Kim CH, Park HJ, Seong YS, Kim BS, et al. Immune Evasion of Enterococcus faecalis by an Extracellular Gelatinase That Cleaves C3 and iC3b. J Immunol. 2008;181(9):6328\u201336. Available from: https:\/\/www.jimmunol.org\/content\/181\/9\/6328. Cited 2022 Aug 7.","journal-title":"J Immunol"},{"issue":"4","key":"3243_CR55","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1111\/j.1365-2958.2009.06703.x","volume":"72","author":"VC Thomas","year":"2009","unstructured":"Thomas VC, Hiromasa Y, Harms N, Thurlow L, Tomich J, Hancock LE. A fratricidal mechanism is responsible for eDNA release and contributes to biofilm development of Enterococcus faecalis. Mol Microbiol. 2009;72(4):1022\u201336. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1111\/j.1365-2958.2009.06703.x. Cited 2022 Aug 7.","journal-title":"Mol Microbiol"},{"issue":"1","key":"3243_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13104-017-3088-5","volume":"11","author":"L Shokoohizadeh","year":"2018","unstructured":"Shokoohizadeh L, Ekrami A, Labibzadeh M, Ali L, Alavi SM. Antimicrobial resistance patterns and virulence factors of enterococci isolates in hospitalized burn patients. BMC Research Notes. 2018;11(1):1\u20135. Available from: https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/s13104-017-3088-5. Cited 2023 Oct 5.","journal-title":"BMC Research Notes"},{"issue":"5","key":"3243_CR57","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.ijmm.2008.10.001","volume":"299","author":"A H\u00e4llgren","year":"2009","unstructured":"H\u00e4llgren A, Claesson C, Saeedi B, Monstein HJ, Hanberger H, Nilsson LE. Molecular detection of aggregation substance, enterococcal surface protein, and cytolysin genes and in vitro adhesion to urinary catheters of Enterococcus faecalis and E. faecium of clinical origin. Int J Med Microbiol. 2009;299(5):323\u201332.","journal-title":"Int J Med Microbiol"},{"issue":"22","key":"3243_CR58","doi-asserted-by":"publisher","first-page":"8233","DOI":"10.1128\/JB.01205-07","volume":"189","author":"E Heikens","year":"2007","unstructured":"Heikens E, Bonten MJM, Willems RJL. Enterococcal surface protein esp is important for biofilm formation of Enterococcus faecium E1162. J Bacteriol. 2007;189(22):8233\u201340. Available from: https:\/\/journals.asm.org\/doi\/10.1128\/JB.01205-07. Cited 2022 Aug 7.","journal-title":"J Bacteriol"},{"issue":"9259","key":"3243_CR59","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/S0140-6736(00)04205-7","volume":"357","author":"RJL Willems","year":"2001","unstructured":"Willems RJL, Homan W, Top J, Van Santen-Verheuvel M, Tribe D, Manzioros X, et al. Variant esp gene as a marker of a distinct genetic lineage of vancomycinresistant Enterococcus faecium spreading in hospitals. The Lancet. 2001;357(9259):853\u20135.","journal-title":"The Lancet"},{"issue":"3","key":"3243_CR60","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/j.1574-695X.2008.00383.x","volume":"52","author":"J Top","year":"2008","unstructured":"Top J, Willems R, Bonten M. Emergence of CC17 Enterococcus faecium: from commensal to hospital-adapted pathogen. FEMS Immunol Med Microbiol. 2008;52(3):297\u2013308. Available from: https:\/\/doi.org\/10.1111\/j.1574-695X.2008.00383.x. Cited 2023 Oct 5.","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"7","key":"3243_CR61","doi-asserted-by":"publisher","first-page":"2832","DOI":"10.1128\/IAI.01218-08","volume":"77","author":"F Lebreton","year":"2009","unstructured":"Lebreton F, Riboulet-Bisson E, Serror P, Sanguinetti M, Posteraro B, Torelli R, et al. ace, which encodes an adhesin in Enterococcus faecalis, is regulated by Ers and is involved in virulence. Infect Immun. 2009;77(7):2832\u20139. Available from: https:\/\/journals.asm.org\/doi\/10.1128\/IAI.01218-08. Cited 2022 Aug 7.","journal-title":"Infect Immun"},{"issue":"11","key":"3243_CR62","doi-asserted-by":"publisher","first-page":"7772","DOI":"10.1128\/IAI.73.11.7772-7774.2005","volume":"73","author":"EC Nannini","year":"2005","unstructured":"Nannini EC, Teng F, Singh KV, Murray BE. Decreased virulence of a gls24 mutant of Enterococcus faecalis OG1RF in an experimental endocarditis model. Infect Immun. 2005;73(11):7772\u20134. Available from: https:\/\/journals.asm.org\/doi\/10.1128\/IAI.73.11.7772-7774.2005. Cited 2022 Aug 7.","journal-title":"Infect Immun"},{"issue":"8","key":"3243_CR63","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1093\/infdis\/jiq160","volume":"203","author":"T Choudhury","year":"2011","unstructured":"Choudhury T, Singh KV, Sillanp\u00e4\u00e4 J, Nallapareddy SR, Murray BE. Importance of two enterococcus faecium Loci encoding Gls-like proteins for In Vitro bile salts stress response and virulence. J Infect Dis. 2011;203(8):1147. Cited 2023 Oct 5.","journal-title":"J Infect Dis."},{"issue":"8","key":"3243_CR64","doi-asserted-by":"publisher","first-page":"103982","DOI":"10.1016\/j.resmic.2022.103982","volume":"173","author":"V Wasselin","year":"2022","unstructured":"Wasselin V, Budin-Verneuil A, Rinc\u00e9 I, L\u00e9ger L, Boukerb AM, Hartke A, et al. The enigmatic physiological roles of AhpCF, Gpx, Npr and Kat in peroxide stress response of Enterococcus faecium. Res Microbiol. 2022;173(8):103982.","journal-title":"Res Microbiol"},{"issue":"6","key":"3243_CR65","first-page":"1749","volume":"155","author":"K Fisher","year":"2009","unstructured":"Fisher K, Phillips C. The ecology, epidemiology and virulence of Enterococcus. Microbiology (N Y). 2009;155(6):1749\u201357.","journal-title":"Microbiology (N Y)"},{"issue":"3","key":"3243_CR66","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1086\/315752","volume":"182","author":"RJL Willems","year":"2000","unstructured":"Willems RJL, Top J, Van den Braak N, Van Belkum A, Endtz H, Mevius D, et al. Host specificity of vancomycin-resistant enterococcus faecium. J Infect Dis. 2000;182(3):816\u201323. Available from: https:\/\/doi.org\/10.1086\/315752. Cited 2023 Oct 3.","journal-title":"J Infect Dis"},{"issue":"6","key":"3243_CR67","doi-asserted-by":"publisher","first-page":"821","DOI":"10.3201\/1106.041204","volume":"11","author":"RJL Willems","year":"2005","unstructured":"Willems RJL, Top J, Van Santen M, Robinson DA, Coque TM, Baquero F, et al. Global spread of vancomycin-resistant enterococcus faecium from distinct nosocomial genetic complex. Emerg Infect Dis. 2005;11(6)821. Cited 2023 Oct 3.","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"3243_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/mBio.00318-11","volume":"3","author":"KL Palmer","year":"2012","unstructured":"Palmer KL, Godfrey P, Griggs A, Kos VN, Zucker J, Desjardins C, et al. Comparative genomics of enterococci: variation in enterococcus faecalis, clade structure in E. faecium, and defining characteristics of E. gallinarum and E. casseliflavus. mBio. 2012;3(1):1\u201311.","journal-title":"mBio"},{"issue":"7","key":"3243_CR69","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1093\/cid\/ciw872","volume":"64","author":"KE Raven","year":"2017","unstructured":"Raven KE, Gouliouris T, Brodrick H, Coll F, Brown NM, Reynolds R, et al. Complex routes of nosocomial vancomycin-resistant enterococcus faecium transmission revealed by genome sequencing. Clin Infect Dis. 2017;64(7):886\u201393. Available from: https:\/\/academic.oup.com\/cid\/article\/64\/7\/886\/3051757. Cited 2022 Aug 4.","journal-title":"Clin Infect Dis"},{"issue":"8","key":"3243_CR70","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1093\/gbe\/evt111","volume":"5","author":"M De Been","year":"2013","unstructured":"De Been M, Van Schaik W, Cheng L, Corander J, Willems RJ. Recent recombination events in the core genome are associated with adaptive evolution in enterococcus faecium. Genome Biol Evol. 2013;5(8):1524\u201335. Available from: https:\/\/doi.org\/10.1093\/gbe\/evt111. Cited 2023 Oct 3.","journal-title":"Genome Biol Evol"},{"key":"3243_CR71","doi-asserted-by":"crossref","unstructured":"van Hal SJ, Willems RJL, Gouliouris T, Ballard SA, Coque TM, Hammerum AM, et al. The interplay between community and hospital Enterococcus faecium clones within health-care settings: a genomic analysis. Lancet Microbe. 2022;3(2):e133\u201341. Available from: http:\/\/www.thelancet.com\/article\/S2666524721002366\/fulltext. Cited 2022 Aug 15.","DOI":"10.1016\/S2666-5247(21)00236-6"},{"key":"3243_CR72","doi-asserted-by":"crossref","unstructured":"Zhou Z, Alikhan NF, Sergeant MJ, Luhmann N, Vaz C, Francisco AP, et al. GrapeTree: visualization of core genomic relationships among 100,000 bacterial pathogens. 2018. Available from: http:\/\/www.genome.org\/cgi\/doi\/10.1101\/gr.232397.117. Cited 2023 Aug 1.","DOI":"10.1101\/216788"},{"issue":"1","key":"3243_CR73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2334-11-80","volume":"11","author":"G Werner","year":"2011","unstructured":"Werner G, Fleige C, Geringer U, van Schaik W, Klare I, Witte W. IS element IS16 as a molecular screening tool to identify hospital-associated strains of Enterococcus faecium. BMC Infect Dis. 2011;11(1):1\u20138.","journal-title":"BMC Infect Dis"},{"issue":"3","key":"3243_CR74","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1093\/jac\/dkx455","volume":"73","author":"G Van den Bunt","year":"2018","unstructured":"Van den Bunt G, Top J, Hordijk J, De Greeff SC, Mughini-Gras L, Corander J, et al. Intestinal carriage of ampicillin- and vancomycin-resistant Enterococcus faecium in humans, dogs and cats in the Netherlands. J Antimicrob Chemother. 2018;73(3):607\u201314. Available from: https:\/\/doi.org\/10.1093\/jac\/dkx455. Cited 2023 Oct 16.","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"3243_CR75","doi-asserted-by":"publisher","first-page":"e30187","DOI":"10.1371\/journal.pone.0030187","volume":"7","author":"J Galloway-Pe\u00f1a","year":"2012","unstructured":"Galloway-Pe\u00f1a J, Roh JH, Latorre M, Qin X, Murray BE. Genomic and SNP analyses demonstrate a distant separation of the hospital and community-associated clades of enterococcus faecium. PLoS One. 2012;7(1):e30187.","journal-title":"PLoS One"},{"issue":"10","key":"3243_CR76","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1101\/gr.204024.116","volume":"26","author":"KE Raven","year":"2016","unstructured":"Raven KE, Reuter S, Reynolds R, Brodrick HJ, Russell JE, T\u00f6r\u00f6k ME, et al. A decade of genomic history for healthcare-associated Enterococcus faecium in the United Kingdom and Ireland. Genome Res. 2016;26(10):1388\u201396. Available from: https:\/\/genome.cshlp.org\/content\/26\/10\/1388.full. Cited 2022 Aug 3.","journal-title":"Genome Res"},{"issue":"1","key":"3243_CR77","doi-asserted-by":"publisher","first-page":"3937","DOI":"10.1038\/s41598-020-61002-5","volume":"10","author":"R Zaheer","year":"2020","unstructured":"Zaheer R, Cook SR, Barbieri R, Goji N, Cameron A, Petkau A, et al. Surveillance of Enterococcus spp. reveals distinct species and antimicrobial resistance diversity across a One-Health continuum. Sci Rep. 2020;10(1):3937.","journal-title":"Sci Rep."},{"issue":"1","key":"3243_CR78","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.ijfoodmicro.2006.07.023","volume":"113","author":"WK Jung","year":"2007","unstructured":"Jung WK, Lim JY, Kwon NH, Kim JM, Hong SK, Koo HC, et al. Vancomycin-resistant enterococci from animal sources in Korea. Int J Food Microbiol. 2007;113(1):102\u20137.","journal-title":"Int J Food Microbiol"},{"key":"3243_CR79","doi-asserted-by":"publisher","unstructured":"Egan SA, Kavanagh NL, Shore AC, Mollerup S, Samaniego Castruita JA, O\u2019connell B, et al. Genomic analysis of 600 vancomycin-resistant Enterococcus faecium reveals a high prevalence of ST80 and spread of similar vanA regions via IS1216E and plasmid transfer in diverse genetic lineages in Ireland. 2021. Available from: https:\/\/doi.org\/10.1093\/jac\/dkab393. Cited 2022 Aug 3.","DOI":"10.1093\/jac\/dkab393"},{"issue":"1","key":"3243_CR80","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1128\/AEM.03108-13","volume":"80","author":"EB Kim","year":"2014","unstructured":"Kim EB, Marco ML. Nonclinical and clinical enterococcus faecium strains, but not enterococcus faecalis strains, have distinct structural and functional genomic features. Appl Environ Microbiol. 2014;80(1):154\u201365.","journal-title":"Appl Environ Microbiol"},{"issue":"10","key":"3243_CR81","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.tim.2017.04.010","volume":"25","author":"K Poole","year":"2017","unstructured":"Poole K. At the nexus of antibiotics and metals: the impact of Cu and Zn on antibiotic activity and resistance. Trends Microbiol. 2017;25(10):820\u201332.","journal-title":"Trends Microbiol"},{"issue":"8","key":"3243_CR82","doi-asserted-by":"publisher","first-page":"004948","DOI":"10.1099\/ijsem.0.004948","volume":"71","author":"MV Belloso Daza","year":"2021","unstructured":"Belloso Daza MV, Cortimiglia C, Bassi D, Cocconcelli PS. Genome-based studies indicate that the enterococcus faecium clade b strains belong to enterococcus lactis species and lack of the hospital infection associated markers. Int J Syst Evol Microbiol. 2021;71(8):004948. Available from: https:\/\/www.microbiologyresearch.org\/content\/journal\/ijsem\/10.1099\/ijsem.0.004948. Cited 2023 Oct 3.","journal-title":"Int J Syst Evol Microbiol"},{"key":"3243_CR83","doi-asserted-by":"crossref","unstructured":"Leavis HL, Willems RJL, Van Wamel WJB, Schuren FH, Caspers MPM, Bonten MJM. Insertion Sequence-Driven Diversification Creates a Globally Dispersed Emerging Multiresistant Subspecies of E. faecium. 2007. Available from: www.plospathogens.org. Cited 2023 Oct 4.","DOI":"10.1371\/journal.ppat.0030007"},{"issue":"2","key":"3243_CR84","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.chom.2017.12.018","volume":"23","author":"S Zhang","year":"2018","unstructured":"Zhang S, Lebreton F, Mansfield MJ, Miyashita SI, Zhang J, Schwartzman JA, et al. Identification of a botulinum neurotoxin-like toxin in a commensal strain of enterococcus faecium. Cell Host Microbe. 2018;23(2):169\u2013176.e6.","journal-title":"Cell Host Microbe"},{"issue":"1","key":"3243_CR85","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1186\/s12864-018-4887-3","volume":"19","author":"Q He","year":"2018","unstructured":"He Q, Hou Q, Wang Y, Li J, Li W, Kwok LY, et al. Comparative genomic analysis of Enterococcus faecalis: Insights into their environmental adaptations. BMC Genomics. 2018;19(1):527.","journal-title":"BMC Genomics"},{"issue":"10","key":"3243_CR86","doi-asserted-by":"publisher","first-page":"001590","DOI":"10.1099\/jmm.0.001590","volume":"71","author":"RJ Leigh","year":"2022","unstructured":"Leigh RJ, McKenna C, McWade R, Lynch B, Walsh F. Comparative genomics and pangenomics of vancomycin-resistant and susceptible Enterococcus faecium from Irish hospitals. J Med Microbiol. 2022;71(10):001590. Available from: https:\/\/www.microbiologyresearch.org\/content\/journal\/jmm\/10.1099\/jmm.0.001590. Cited 2023 Feb 27.","journal-title":"J Med Microbiol"},{"issue":"1","key":"3243_CR87","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-24614-6","volume":"8","author":"KWC Leong","year":"2018","unstructured":"Leong KWC, Cooley LA, Anderson TL, Gautam SS, McEwan B, Wells A, et al. Emergence of vancomycin-resistant enterococcus faecium at an Australian hospital: A whole genome sequencing analysis. Sci Rep. 2018;8(1):1\u201311. Available from: https:\/\/www.nature.com\/articles\/s41598-018-24614-6. Cited 2022 Aug 4.","journal-title":"Sci Rep"},{"issue":"33","key":"3243_CR88","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.meegid.2015.05.012","volume":"1","author":"JX Yang","year":"2015","unstructured":"Yang JX, Li T, Ning YZ, Shao DH, Liu J, Wang SQ, et al. Molecular characterization of resistance, virulence and clonality in vancomycin-resistant Enterococcus faecium and Enterococcus faecalis: A hospital-based study in Beijing, China. Infect Genet Evol. 2015;1(33):253\u201360.","journal-title":"Infect Genet Evol"},{"issue":"10","key":"3243_CR89","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1128\/AAC.40.10.2285","volume":"40","author":"LA Devriese","year":"1996","unstructured":"Devriese LA, Ieven M, Goossens H, Vandamme P, Pot B, Hommez J, et al. Presence of vancomycin-resistant enterococci in farm and pet animals. Antimicrob Agents Chemother. 1996;40(10):2285\u20137. Available from: https:\/\/journals.asm.org\/journal\/aac. Cited 2022 Aug 4.","journal-title":"Antimicrob Agents Chemother"},{"key":"3243_CR90","doi-asserted-by":"crossref","unstructured":"Howden BP, Holt KE, Lam MMC, Seemann T, Ballard S, Coombs GW, et al. Genomic insights to control the emergence of vancomycin-resistant enterococci. mBio. 2013;4(4). Available from: https:\/\/journals.asm.org\/doi\/10.1128\/mBio.00412-13. Cited 2022 Aug 3.","DOI":"10.1128\/mBio.00412-13"},{"issue":"3","key":"3243_CR91","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nmicrobiol.2015.33","volume":"1","author":"KE Raven","year":"2016","unstructured":"Raven KE, Reuter S, Gouliouris T, Reynolds R, Russell JE, Brown NM, et al. Genome-based characterization of hospital-adapted Enterococcus faecalis lineages. Nature Microbiology. 2016;1(3):1\u20137. Available from: https:\/\/www.nature.com\/articles\/nmicrobiol201533. Cited 2022 Aug 3.","journal-title":"Nature Microbiology"},{"issue":"6","key":"3243_CR92","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1093\/jac\/dky039","volume":"73","author":"F Lebreton","year":"2018","unstructured":"Lebreton F, Valentino MD, Schaufler K, Earl AM, Cattoir V, Gilmore MS. Transferable vancomycin resistance in clade B commensal-type Enterococcus faecium. J Antimicrob Chemother. 2018;73(6):1479\u201386.","journal-title":"J Antimicrob Chemother"},{"key":"3243_CR93","doi-asserted-by":"crossref","unstructured":"Top J, Sinnige JC, Brouwer EC, Werner G, Corander J, Severin JA, et al. Identification of a Novel Genomic Island Associated with vanD-Type Vancomycin Resistance in Six Dutch Vancomycin-Resistant Enterococcus faecium Isolates. Antimicrob Agents Chemother. 2018;62(3). Cited 2023 Aug 1.","DOI":"10.1128\/AAC.01793-17"},{"issue":"11","key":"3243_CR94","doi-asserted-by":"publisher","first-page":"e0102922","DOI":"10.1128\/aac.01029-22","volume":"66","author":"J Hisatsune","year":"2022","unstructured":"Hisatsune J, Tanimoto K, Kohara T, Myoken Y, Tomita Y, Sugai M. First Isolation of Vancomycin-Resistant Enterococcus faecium Carrying Plasmid-Borne vanD1. Antimicrob Agents Chemother. 2022;66(11):e0102922.","journal-title":"Antimicrob Agents Chemother"},{"key":"3243_CR95","doi-asserted-by":"publisher","unstructured":"Kritsotakis EI, Christidou A, Roumbelaki M, Tselentis Y, Gikas A. The dynamic relationship between antibiotic use and the incidence of vancomycin-resistant Enterococcus: time-series modelling of 7-year surveillance data in a tertiary-care hospital. Clin Microbiol Infect. 2008;14(8):747\u201354. https:\/\/doi.org\/10.1111\/j.1469-0691.2008.02026.x.","DOI":"10.1111\/j.1469-0691.2008.02026.x"},{"issue":"7","key":"3243_CR96","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1086\/666331","volume":"33","author":"JA McKinnell","year":"2012","unstructured":"McKinnell JA, Kunz DF, Chamot E, Patel M, Shirley RM, Moser SA, et al. Association of Vancomycin-Resistant Enterococcus Bacteremia and Ceftriaxone Usage. Infect Control Hosp Epidemiol. 2012;33(7):718\u201324. Cited 2023 Oct 4.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"Supplement_1","key":"3243_CR97","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.1086\/521859","volume":"46","author":"RC Owens","year":"2008","unstructured":"Owens RC, Donskey CJ, Gaynes RP, Loo VG, Muto CA. Antimicrobial-associated risk factors for clostridium difficile Infection. Clin Infect Dis. 2008;46(Supplement_1):S19\u201331. Available from: https:\/\/doi.org\/10.1086\/521859. Cited 2023 Oct 4.","journal-title":"Clin Infect Dis"},{"issue":"12","key":"3243_CR98","doi-asserted-by":"publisher","first-page":"3788","DOI":"10.1128\/JCM.01946-15","volume":"53","author":"M de Been","year":"2015","unstructured":"de Been M, Pinholt M, Top J, Bletz S, Mellmann A, van Schaik W, et al. Core genome multilocus sequence typing scheme for high-resolution typing of enterococcus faecium. J Clin Microbiol. 2015;53(12):3788\u201397. Available from: https:\/\/journals.asm.org\/journal\/jcm. Cited 2022 Aug 3.","journal-title":"J Clin Microbiol"},{"issue":"1","key":"3243_CR99","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13756-022-01136-5","volume":"11","author":"N Saito","year":"2022","unstructured":"Saito N, Kitazawa J, Horiuchi H, Yamamoto T, Kimura M, Inoue F, et al. Interhospital transmission of vancomycin-resistant Enterococcus faecium in Aomori Japan. Antimicrob Resist Infect Control. 2022;11(1):1\u201312. Available from: https:\/\/aricjournal.biomedcentral.com\/articles\/10.1186\/s13756-022-01136-5. Cited 2022 Aug 3.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"9","key":"3243_CR100","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1093\/jac\/dkv142","volume":"70","author":"M Pinholt","year":"2015","unstructured":"Pinholt M, Larner-Svensson H, Littauer P, Moser CE, Pedersen M, Lemming LE, et al. Multiple hospital outbreaks of vanA Enterococcus faecium in Denmark, 2012\u201313, investigated by WGS MLST and PFGE. J Antimicrob Chemother. 2015;70(9):2474\u201382. Available from: https:\/\/academic.oup.com\/jac\/article\/70\/9\/2474\/720798. Cited 2022 Aug 3.","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"3243_CR101","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1093\/jac\/dks469","volume":"68","author":"V Cattoir","year":"2013","unstructured":"Cattoir V, Leclercq R. Twenty-five years of shared life with vancomycin-resistant enterococci: is it time to divorce? J Antimicrob Chemother. 2013;68(4):731\u201342. Available from: https:\/\/academic.oup.com\/jac\/article\/68\/4\/731\/702376. Cited 2022 Aug 3.","journal-title":"J Antimicrob Chemother"},{"key":"3243_CR102","doi-asserted-by":"publisher","unstructured":"Gouliouris T, Coll F, Ludden C, Blane B, Raven KE, Naydenova P, et al. Quantifying acquisition and transmission of Enterococcus faecium using genomic surveillance. 2021. Available from: https:\/\/doi.org\/10.1038\/s41564-020-00806-7. Cited 2022 Aug 4.","DOI":"10.1038\/s41564-020-00806-7"},{"issue":"3","key":"3243_CR103","doi-asserted-by":"publisher","first-page":"e01520","DOI":"10.1128\/JCM.01520-17","volume":"56","author":"KE Raven","year":"2018","unstructured":"Raven KE, Gouliouris T, Parkhill J, Peacock SJ. Genome-based analysis of Enterococcus faecium bacteremia associated with recurrent and mixed-strain infection. J Clin Microbiol. 2018;56(3):e01520\u201317.","journal-title":"J Clin Microbiol"},{"issue":"452","key":"3243_CR104","doi-asserted-by":"publisher","first-page":"6115","DOI":"10.1126\/scitranslmed.aar6115","volume":"10","author":"SJ Pidot","year":"2018","unstructured":"Pidot SJ, Gao W, Buultjens AH, Monk IR, Guerillot R, Carter GP, et al. Increasing tolerance of hospital Enterococcus faecium to handwash alcohols. Sci Transl Med. 2018;10(452):6115. Available from: https:\/\/www.science.org\/doi\/10.1126\/scitranslmed.aar6115. Cited 2023 Oct 4.","journal-title":"Sci Transl Med"},{"key":"3243_CR105","doi-asserted-by":"crossref","unstructured":"Bo\u00ebtius Hertz F, Leth Nielsen K, Olsen MH, R\u00f8ddik Ebdrup S, Nielsen C, Kirkby N, et al. Vancomycin-resistant Enterococcus faecium: should we screen on admission? APMIS. 2022. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1111\/apm.13263. Cited 2022 Aug 4.","DOI":"10.1111\/apm.13263"},{"issue":"4","key":"3243_CR106","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1101\/gr.232629.117","volume":"29","author":"T Gouliouris","year":"2019","unstructured":"Gouliouris T, Raven KE, Moradigaravand D, Ludden C, Coll F, Blane B, et al. Detection of vancomycin-resistant Enterococcus faecium hospital-adapted lineages in municipal wastewater treatment plants indicates widespread distribution and release into the environment. Genome Res. 2019;29(4):626\u201334. Available from: https:\/\/genome.cshlp.org\/content\/29\/4\/626.full. Cited 2022 Aug 4.","journal-title":"Genome Res"},{"key":"3243_CR107","doi-asserted-by":"crossref","unstructured":"Permana B, Harris PNA, Runnegar N, Lindsay M, Henderson BC, Playford EG, et al. Using Genomics To Investigate an Outbreak of Vancomycin-Resistant Enterococcus faecium ST78 at a Large Tertiary Hospital in Queensland. Microbiol Spectr [Internet]. 2023;11(3). Available from: https:\/\/journals.asm.org\/doi\/10.1128\/spectrum.04204-22. Cited 2023 Oct 12.","DOI":"10.1128\/spectrum.04204-22"},{"key":"3243_CR108","doi-asserted-by":"crossref","unstructured":"Leistner R, Kohlmorgen B, Brodzinski A, Schwab F, Lemke E, Zakonsky G, et al. Environmental cleaning to prevent hospital-acquired infections on non-intensive care units: a pragmatic, single-centre, cluster randomized controlled, crossover trial comparing soap-based, disinfection and probiotic cleaning. 2023. Available from: www.thelancet.com. Cited 2023 Oct 8.","DOI":"10.1016\/j.eclinm.2023.101958"},{"issue":"12","key":"3243_CR109","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.1093\/cid\/ciab001","volume":"73","author":"L El Haddad","year":"2021","unstructured":"El Haddad L, Hanson BM, Arias CA, Ghantoji SS, Harb CP, Stibich M, et al. Emergence and transmission of daptomycin and vancomycin-resistant enterococci between patients and hospital rooms. Clin Infect Dis. 2021;73(12):2306\u201313. Available from: https:\/\/academic.oup.com\/cid\/article\/73\/12\/2306\/6075650. Cited 2022 Oct 11.","journal-title":"Clin Infect Dis"},{"key":"3243_CR110","doi-asserted-by":"publisher","first-page":"599285","DOI":"10.3389\/fpubh.2021.599285","volume":"9","author":"LA Rogers","year":"2021","unstructured":"Rogers LA, Strong K, Cork SC, McAllister TA, Liljebjelke K, Zaheer R, et al. The role of whole genome sequencing in the surveillance of antimicrobial resistant enterococcus spp.: a scoping review. Front Public Health. 2021;9:599285. Cited 2023 Oct 16.","journal-title":"Front Public Health"},{"issue":"3","key":"3243_CR111","doi-asserted-by":"publisher","first-page":"e1277","DOI":"10.1093\/cid\/ciac726","volume":"76","author":"BM Forde","year":"2023","unstructured":"Forde BM, Bergh H, Cuddihy T, Hajkowicz K, Hurst T, Playford EG, et al. Clinical Implementation of Routine Whole-genome Sequencing for Hospital Infection Control of Multi-drug Resistant Pathogens. Clin Infect Dis. 2023;76(3):e1277\u201384. Available from: https:\/\/doi.org\/10.1093\/cid\/ciac726. Cited 2023 Oct 16.","journal-title":"Clin Infect Dis"},{"issue":"12","key":"3243_CR112","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1164\/rccm.201703-0537LE","volume":"196","author":"KM Pendleton","year":"2017","unstructured":"Pendleton KM, Erb-Downward JR, Bao Y, Branton WR, Falkowski NR, Newton DW, et al. Rapid pathogen identification in bacterial pneumonia using real-time metagenomics. Am J Respir Crit Care Med. 2017;196(12):1610\u20132. Available from: https:\/\/www.atsjournals.org. Cited 2023 Oct 16.","journal-title":"Am J Respir Crit Care Med"},{"issue":"Supplementary_3","key":"3243_CR113","doi-asserted-by":"publisher","first-page":"S331","DOI":"10.1093\/infdis\/jiz151","volume":"221","author":"AD Chiang","year":"2020","unstructured":"Chiang AD, Dekker JP. From the pipeline to the bedside: advances and challenges in clinical metagenomics. J Infect Dis. 2020;221(Supplementary_3):S331\u201340. Available from: https:\/\/doi.org\/10.1093\/infdis\/jiz151. Cited 2023 Oct 16.","journal-title":"J Infect Dis"},{"issue":"4","key":"3243_CR114","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.idc.2021.07.002","volume":"35","author":"S Joshi","year":"2021","unstructured":"Joshi S, Shallal A, Zervos M. Vancomycin-resistant enterococci: epidemiology, infection prevention, and control. Infect Dis Clin North Am. 2021;35(4):953\u201368. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34752227\/. Cited 2023 Oct 12.","journal-title":"Infect Dis Clin North Am"},{"key":"3243_CR115","doi-asserted-by":"crossref","unstructured":"Cairns KA, Udy AA, Peel TN, Abbott IJ, Dooley MJ, Peleg AY. Therapeutics for vancomycin-resistant enterococcal bloodstream infections. Clin Microbiol Rev. 2023;36(2). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/37067406\/. Cited 2023 Oct 9.","DOI":"10.1128\/cmr.00059-22"},{"key":"3243_CR116","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3389\/fmicb.2021.637656","volume":"12","author":"AM Turner","year":"2021","unstructured":"Turner AM, Lee JYH, Gorrie CL, Howden BP, Carter GP. Genomic insights into last-line antimicrobial resistance in multidrug-resistant staphylococcus and vancomycin-resistant enterococcus. Front Microbiol. 2021;12:16. Cited 2023 Oct 12.","journal-title":"Front Microbiol"},{"issue":"7","key":"3243_CR117","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1093\/jac\/dkaa075","volume":"75","author":"SA Egan","year":"2020","unstructured":"Egan SA, Shore AC, O\u2019Connell B, Brennan GI, Coleman DC. Linezolid resistance in Enterococcus faecium and Enterococcus faecalis from hospitalized patients in Ireland: high prevalence of the MDR genes optrA and poxtA in isolates with diverse genetic backgrounds. J Antimicrob Chemother. 2020;75(7):1704\u201311. Available from: https:\/\/doi.org\/10.1093\/jac\/dkaa075. Cited 2023 Oct 12.","journal-title":"J Antimicrob Chemother"},{"issue":"10","key":"3243_CR118","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1093\/jac\/dkz263","volume":"74","author":"H Elghaieb","year":"2019","unstructured":"Elghaieb H, Freitas AR, Abbassi MS, Novais C, Zouari M, Hassen A, et al. Dispersal of linezolid-resistant enterococci carrying poxtA or optrA in retail meat and food-producing animals from Tunisia. J Antimicrob Chemother. 2019;74(10):2865\u20139. Available from: https:\/\/doi.org\/10.1093\/jac\/dkz263. Cited 2023 Oct 16.","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"3243_CR119","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1093\/jac\/dkz198","volume":"74","author":"CW Lei","year":"2019","unstructured":"Lei CW, Kang ZZ, Wu SK, Chen YP, Kong LH, Wang HN. Detection of the phenicol\u2013oxazolidinone\u2013tetracycline resistance gene poxtA in Enterococcus faecium and Enterococcus faecalis of food-producing animal origin in China. J Antimicrob Chemother. 2019;74(8):2459\u201361. Available from: https:\/\/doi.org\/10.1093\/jac\/dkz198. Cited 2023 Oct 16.","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"3243_CR120","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.idc.2020.08.004","volume":"34","author":"WR Miller","year":"2020","unstructured":"Miller WR, Murray BE, Rice LB, Arias CA. Resistance in vancomycin-resistant enterococci. Infect Dis Clin North Am. 2020;34(4):751. Cited 2023 Oct 16.","journal-title":"Infect Dis Clin North Am"},{"issue":"3","key":"3243_CR121","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1093\/jac\/dkh546","volume":"55","author":"JN Steenbergen","year":"2005","unstructured":"Steenbergen JN, Alder J, Thorne GM, Tally FP. Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections. J Antimicrob Chemother. 2005;55(3):283\u20138.","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"3243_CR122","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-020-15257-1","volume":"11","author":"F Grein","year":"2020","unstructured":"Grein F, M\u00fcller A, Scherer KM, Liu X, Ludwig KC, Kl\u00f6ckner A, et al. Ca2+-Daptomycin targets cell wall biosynthesis by forming a tripartite complex with undecaprenyl-coupled intermediates and membrane lipids. Nat Commun. 2020;11(1):1\u201311. Available from: https:\/\/www.nature.com\/articles\/s41467-020-15257-1. Cited 2022 Aug 8.","journal-title":"Nat Commun"},{"issue":"5","key":"3243_CR123","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.ijantimicag.2014.08.002","volume":"44","author":"JM Munita","year":"2014","unstructured":"Munita JM, Murray BE, Arias CA. Daptomycin for the treatment of bacteraemia due to vancomycin-resistant enterococci. Int J Antimicrob Agents. 2014;44(5):387\u201395.","journal-title":"Int J Antimicrob Agents"},{"key":"3243_CR124","unstructured":"FDA Rationale for Recognition Decision: Daptomycin | FDA. Available from: https:\/\/www.fda.gov\/drugs\/development-resources\/fda-rationale-recognition-decision-daptomycin. Cited 2022 Aug 8."},{"issue":"6","key":"3243_CR125","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1093\/cid\/civ449","volume":"61","author":"JA McKinnell","year":"2015","unstructured":"McKinnell JA, Arias CA. Editorial Commentary: Linezolid vs Daptomycin for vancomycin-resistant enterococci: the evidence gap between trials and clinical experience. Clin Infect Dis. 2015;61(6):879\u201382. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/26063714\/. Cited 2022 Aug 8.","journal-title":"Clin Infect Dis"},{"key":"3243_CR126","doi-asserted-by":"publisher","unstructured":"Narayanan N, Rai R, Vaidya P, Desai A, Bhowmick T, Weinstein MP. Comparison of linezolid and daptomycin for the treatment of vancomycin-resistant enterococcal bacteremia. 2019;6. https:\/\/doi.org\/10.1177\/2049936119828964,\u00a0https:\/\/journals.sagepub.com\/doi\/full\/10.1177\/2049936119828964?rfr_dat=cr_pub++0pubmed&url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org. Cited 2023 Aug 1.","DOI":"10.1177\/2049936119828964"},{"issue":"10","key":"3243_CR127","doi-asserted-by":"publisher","first-page":"5013","DOI":"10.1128\/AAC.00714-13","volume":"57","author":"DW Whang","year":"2013","unstructured":"Whang DW, Miller LG, Partain NM, McKinnell JA. Systematic review and meta-analysis of linezolid and daptomycin for treatment of vancomycin-resistant enterococcal bloodstream infections. Antimicrob Agents Chemother. 2013;57(10):5013\u20138. Available from: https:\/\/journals.asm.org\/doi\/10.1128\/AAC.00714-13. Cited 2022 Aug 8.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"3243_CR128","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-014-0687-9","volume":"14","author":"YC Chuang","year":"2014","unstructured":"Chuang YC, Wang JT, Lin HY, Chang SC. Daptomycin versus linezolid for treatment of vancomycin-resistant enterococcal bacteremia: Systematic review and meta-analysis. BMC Infect Dis. 2014;14(1):1\u201310. Available from: https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-014-0687-9. Cited 2022 Aug 8.","journal-title":"BMC Infect Dis"},{"issue":"2","key":"3243_CR129","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1128\/AAC.01289-13","volume":"58","author":"EP Balli","year":"2014","unstructured":"Balli EP, Venetis CA, Miyakis S. Systematic review and meta-analysis of linezolid versus daptomycin for treatment of vancomycin-resistant enterococcal bacteremia. Antimicrob Agents Chemother. 2014;58(2):734\u20139.","journal-title":"Antimicrob Agents Chemother"},{"key":"3243_CR130","doi-asserted-by":"publisher","unstructured":"Narayanan N, Rai R, Vaidya P, Desai A, Bhowmick T, Weinstein MP. Comparison of linezolid and daptomycin for the treatment of vancomycin-resistant enterococcal bacteremia. 2019;6. Available from: https:\/\/doi.org\/10.1177\/2049936119828964. https:\/\/journals.sagepub.com\/doi\/full\/10.1177\/2049936119828964?rfr_dat=cr_pub++0pubmed&url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org. Cited 2023 Oct 9.","DOI":"10.1177\/2049936119828964"},{"issue":"6","key":"3243_CR131","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1093\/cid\/civ444","volume":"61","author":"NS Britt","year":"2015","unstructured":"Britt NS, Potter EM, Patel N, Steed ME. Comparison of the effectiveness and safety of linezolid and daptomycin in vancomycin-resistant enterococcal bloodstream infection: a national cohort study of veterans affairs patients. Clin Infect Dis. 2015;61(6):871\u20138. Available from: https:\/\/academic.oup.com\/cid\/article\/61\/6\/871\/452040. Cited 2022 Aug 8.","journal-title":"Clin Infect Dis"},{"key":"3243_CR132","doi-asserted-by":"crossref","unstructured":"Britt NS, Potter EM, Patel N, Steed ME. Effect of continuous and sequential therapy among Veterans receiving daptomycin or linezolid for vancomycin-resistant Enterococcus faecium bacteremia. Antimicrob Agents Chemother. 2017;61(5). Available from: https:\/\/journals.asm.org\/doi\/10.1128\/AAC.02216-16. Cited 2022 Aug 8.","DOI":"10.1128\/AAC.02216-16"},{"issue":"9","key":"3243_CR133","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1093\/jac\/dky072","volume":"73","author":"F Foolad","year":"2018","unstructured":"Foolad F, Taylor BD, Shelburne SA, Arias CA, Aitken SL. Association of daptomycin dosing regimen and mortality in patients with VRE bacteraemia: a review. J Antimicrob Chemother. 2018;73(9):2277\u201383. Available from: https:\/\/academic.oup.com\/jac\/article\/73\/9\/2277\/4934159. Cited 2022 Aug 8.","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"3243_CR134","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1093\/jac\/dku113","volume":"69","author":"AH Snyder","year":"2014","unstructured":"Snyder AH, Werth BJ, Barber KE, Sakoulas G, Rybak MJ. Evaluation of the novel combination of daptomycin plus ceftriaxone against vancomycin-resistant enterococci in an in vitro pharmacokinetic\/pharmacodynamic simulated endocardial vegetation model. J Antimicrob Chemother. 2014;69(8):2148\u201354.","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"3243_CR135","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1093\/jac\/dkv007","volume":"70","author":"JR Smith","year":"2014","unstructured":"Smith JR, Barber KE, Raut A, Aboutaleb M, Sakoulas G, Rybak MJ. \u03b2-Lactam combinations with daptomycin provide synergy against vancomycin-resistant Enterococcus faecalis and Enterococcus faecium. J Antimicrob Chemother. 2014;70(6):1738\u201343.","journal-title":"J Antimicrob Chemother"},{"issue":"10","key":"3243_CR136","doi-asserted-by":"publisher","first-page":"5716","DOI":"10.1128\/AAC.00687-16","volume":"60","author":"ADH Snyder","year":"2016","unstructured":"Snyder ADH, Werth BJ, Nonejuie P, McRoberts JP, Pogliano J, Sakoulas G, et al. Fosfomycin enhances the activity of daptomycin against vancomycin-resistant enterococci in an in vitro pharmacokinetic-pharmacodynamic model. Antimicrob Agents Chemother. 2016;60(10):5716.","journal-title":"Antimicrob Agents Chemother"},{"key":"3243_CR137","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.3389\/fmicb.2017.01541","volume":"8","author":"L Sun","year":"2017","unstructured":"Sun L, Zhang P, Qu T, Chen Y, Hua X, Shi K, et al. Identification of novel conjugative plasmids with multiple copies of fosb that confer high-level fosfomycin resistance to vancomycin-resistant enterococci. Front Microbiol. 2017;8:1541.","journal-title":"Front Microbiol"},{"issue":"8","key":"3243_CR138","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1592\/phco.26.8.1099","volume":"26","author":"WE Rose","year":"2006","unstructured":"Rose WE, Rybak MJ. Tigecycline: first of a new class of antimicrobial agents. Pharmacotherapy. 2006;26(8):1099\u2013110. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1592\/phco.26.8.1099. Cited 2023 Dec 5.","journal-title":"Pharmacotherapy"},{"issue":"Supplement_5","key":"3243_CR139","doi-asserted-by":"publisher","first-page":"S354","DOI":"10.1086\/431676","volume":"41","author":"T Babinchak","year":"2005","unstructured":"Babinchak T, Ellis-Grosse E, Dartois N, Rose GM, Loh E. The Efficacy and Safety of Tigecycline for the Treatment of Complicated Intra-Abdominal Infections: Analysis of Pooled Clinical Trial Data. Clin Infect Dis. 2005;41(Supplement_5):S354\u201367. Available from: https:\/\/doi.org\/10.1086\/431676. Cited 2023 Dec 5.","journal-title":"Clin Infect Dis"},{"key":"3243_CR140","doi-asserted-by":"publisher","first-page":"720647","DOI":"10.3389\/fmed.2021.720647","volume":"8","author":"M Dadashi","year":"2021","unstructured":"Dadashi M, Sharifian P, Bostanshirin N, Hajikhani B, Bostanghadiri N, Khosravi-Dehaghi N, et al. The global prevalence of daptomycin, tigecycline, and linezolid-resistant enterococcus faecalis and enterococcus faecium strains from human clinical samples: a systematic review and meta-analysis. Front Med (Lausanne). 2021;8:720647. Cited 2023 Dec 4.","journal-title":"Front Med (Lausanne)"},{"issue":"40","key":"3243_CR141","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.drup.2018.10.002","volume":"1","author":"JK Bender","year":"2018","unstructured":"Bender JK, Cattoir V, Hegstad K, Sadowy E, Coque TM, Westh H, et al. Update on prevalence and mechanisms of resistance to linezolid, tigecycline and daptomycin in enterococci in Europe: Towards a common nomenclature. Drug Resist Updat. 2018;1(40):25\u201339.","journal-title":"Drug Resist Updat"},{"issue":"4","key":"3243_CR142","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1093\/jac\/dkv420","volume":"71","author":"S Fiedler","year":"2016","unstructured":"Fiedler S, Bender JK, Klare I, Halbedel S, Grohmann E, Szewzyk U, et al. Tigecycline resistance in clinical isolates of Enterococcus faecium is mediated by an upregulation of plasmid-encoded tetracycline determinants tet(L) and tet(M). J Antimicrob Chemother. 2016;71(4):871\u201381. Available from: https:\/\/doi.org\/10.1093\/jac\/dkv420. Cited 2023 Dec 5.","journal-title":"J Antimicrob Chemother"},{"issue":"9","key":"3243_CR143","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1038\/s41564-019-0445-2","volume":"4","author":"T He","year":"2019","unstructured":"He T, Wang R, Liu D, Walsh TR, Zhang R, Lv Y, et al. Emergence of plasmid-mediated high-level tigecycline resistance genes in animals and humans. Nat Microbiol. 2019;4(9):1450\u20136. Available from: https:\/\/www.nature.com\/articles\/s41564-019-0445-2. Cited 2023 Dec 4.","journal-title":"Nat Microbiol"},{"issue":"5790","key":"3243_CR144","first-page":"1126","volume":"313","author":"HL Cash","year":"2006","unstructured":"Cash HL, Whitham CV, Behrendt CL, Hooper LV. Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science (1979). 2006;313(5790):1126\u201330. Available from: https:\/\/www.science.org\/doi\/10.1126\/science.1127119. Cited 2023 Aug 1.","journal-title":"Science (1979)"},{"issue":"7771","key":"3243_CR145","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/s41586-019-1501-z","volume":"572","author":"SG Kim","year":"2019","unstructured":"Kim SG, Becattini S, Moody TU, Shliaha PV, Littmann ER, Seok R, et al. Microbiota-derived lantibiotic restores resistance against vancomycin-resistant Enterococcus. Nature. 2019;572(7771):665\u20139. Available from: https:\/\/www.nature.com\/articles\/s41586-019-1501-z. Cited 2022 Aug 8.","journal-title":"Nature"},{"key":"3243_CR146","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.chom.2017.04.002","volume":"21","author":"S Caballero","year":"2017","unstructured":"Caballero S, Kim S, Carter RA, Kim GJ, Ling L, Pamer Correspondence EG. Cooperating Commensals Restore Colonization Resistance to Vancomycin-Resistant Enterococcus faecium. Cell Host Microbe. 2017;21:592\u2013602.e4. Available from: https:\/\/doi.org\/10.1016\/j.chom.2017.04.002. Cited 2022 Aug 15.","journal-title":"Cell Host Microbe"},{"issue":"6","key":"3243_CR147","doi-asserted-by":"publisher","first-page":"e01346","DOI":"10.1128\/mBio.01346-15","volume":"6","author":"APA Hendrickx","year":"2015","unstructured":"Hendrickx APA, Top J, Bayjanov JR, Kemperman H, Rogers MRC, Paganelli FL, et al. Antibiotic-driven dysbiosis mediates intraluminal agglutination and alternative segregation of enterococcus faecium from the intestinal epithelium. mBio. 2015;6(6):e01346\u201315. Available from: https:\/\/journals.asm.org\/doi\/10.1128\/mbio.01346-15. Cited 2023 Oct 5.","journal-title":"mBio"},{"issue":"20","key":"3243_CR148","doi-asserted-by":"publisher","first-page":"9352","DOI":"10.1073\/pnas.0913554107","volume":"107","author":"MC Rea","year":"2010","unstructured":"Rea MC, Sit CS, Clayton E, O\u2019Connor PM, Whittal RM, Zheng J, et al. Thuricin CD, a posttranslationally modified bacteriocin with a narrow spectrum of activity against Clostridium difficile. Proc Natl Acad Sci U S A. 2010;107(20):9352\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"3243_CR149","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/femsre\/fuaa039","volume":"45","author":"S Soltani","year":"2021","unstructured":"Soltani S, Hammami R, Cotter PD, Rebuffat S, Said LB, Gaudreau H, et al. Bacteriocins as a new generation of antimicrobials: toxicity aspects and regulations. FEMS Microbiol Rev. 2021;45(1):1\u201324. Available from: https:\/\/academic.oup.com\/femsre\/article\/45\/1\/fuaa039\/5900525. Cited 2022 Aug 8.","journal-title":"FEMS Microbiol Rev"},{"issue":"10","key":"3243_CR150","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/nrmicro1273","volume":"3","author":"PD Cotter","year":"2005","unstructured":"Cotter PD, Hill C, Ross PR. Bacteriocins: developing innate immunity for food. Nat Rev Microbiol. 2005;3(10):777\u201388.","journal-title":"Nat Rev Microbiol"},{"issue":"W1","key":"3243_CR151","doi-asserted-by":"publisher","first-page":"W278","DOI":"10.1093\/nar\/gky383","volume":"46","author":"AJ Van Heel","year":"2018","unstructured":"Van Heel AJ, De Jong A, Song C, Viel JH, Kok J, Kuipers OP. BAGEL4: a user-friendly web server to thoroughly mine RiPPs and bacteriocins. Nucleic Acids Res. 2018;46(W1):W278\u201381. Available from: https:\/\/doi.org\/10.1093\/nar\/gky383. Cited 2023 Oct 16.","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"3243_CR152","doi-asserted-by":"publisher","first-page":"W46","DOI":"10.1093\/nar\/gkad344","volume":"51","author":"K Blin","year":"2023","unstructured":"Blin K, Shaw S, Augustijn HE, Reitz ZL, Biermann F, Alanjary M, et al. antiSMASH 7.0: new and improved predictions for detection, regulation, chemical structures and visualisation. Nucleic Acids Res. 2023;51(W1):W46\u201350. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/37140036\/. Cited 2023 Oct 16.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"3243_CR153","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12864-020-06785-7","volume":"21","author":"MC Walker","year":"2020","unstructured":"Walker MC, Eslami SM, Hetrick KJ, Ackenhusen SE, Mitchell DA, Van Der Donk WA. Precursor peptide-targeted mining of more than one hundred thousand genomes expands the lanthipeptide natural product family. BMC Genomics. 2020;21(1):1\u201317.","journal-title":"BMC Genomics"},{"key":"3243_CR154","doi-asserted-by":"crossref","unstructured":"Yang SC, Lin CH, Sung CT, Fang JY. Antibacterial activities of bacteriocins: application in foods and pharmaceuticals. Front Microbiol. 2014;5(MAY). Cited 2022 Aug 8.","DOI":"10.3389\/fmicb.2014.00241"},{"issue":"11","key":"3243_CR155","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/s41579-021-00569-w","volume":"19","author":"S Heilbronner","year":"2021","unstructured":"Heilbronner S, Krismer B, Br\u00f6tz-Oesterhelt H, Peschel A. The microbiome-shaping roles of bacteriocins. Nat Rev Microbiol. 2021;19(11):726\u201339. Available from: https:\/\/www.nature.com\/articles\/s41579-021-00569-w. Cited 2022 Aug 8.","journal-title":"Nat Rev Microbiol"},{"key":"3243_CR156","doi-asserted-by":"crossref","unstructured":"Phumisantiphong U, Siripanichgon K, Reamtong O, Diraphat P. A novel bacteriocin from Enterococcus faecalis 478 exhibits a potent activity against vancomycin-resistant enterococci. PLoS One. 2017;12(10). Cited 2022 Aug 8.","DOI":"10.1371\/journal.pone.0186415"},{"key":"3243_CR157","doi-asserted-by":"crossref","unstructured":"Almeida-Santos AC, Novais C, Peixe L, Freitas AR. Enterococcus spp. As a producer and target of bacteriocins: A double-edged sword in the antimicrobial resistance crisis context. Antibiotics. 2021;10(10). Cited 2023 Oct 12.","DOI":"10.3390\/antibiotics10101215"},{"issue":"7","key":"3243_CR158","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1128\/AEM.02150-07","volume":"74","author":"M Millette","year":"2008","unstructured":"Millette M, Cornut G, Dupont C, Shareck F, Archambault D, Lacroix M. Capacity of human nisin- and pediocin-producing lactic acid bacteria to reduce intestinal colonization by vancomycin-resistant enterococci. Appl Environ Microbiol. 2008;74(7):1997\u20132003.","journal-title":"Appl Environ Microbiol"},{"issue":"4","key":"3243_CR159","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s10989-016-9572-2","volume":"23","author":"S Panthi","year":"2017","unstructured":"Panthi S, Choi YH, Jee JP, Cho SS, Choi YS, Pradeep GC, et al. Antimicrobial peptide from bacillus strain K1R exhibits ameliorative potential against vancomycin-resistant enterococcus group of organisms. Int J Pept Res Ther. 2017;23(4):419\u201330.","journal-title":"Int J Pept Res Ther"},{"issue":"4","key":"3243_CR160","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1007\/s00284-006-0632-2","volume":"55","author":"R Aunpad","year":"2007","unstructured":"Aunpad R, Na-Bangchang K. Pumilicin 4, a novel bacteriocin with anti-MRSA and Anti-VRE activity produced by newly isolated bacteria Bacillus pumilus strain WAPB4. Curr Microbiol. 2007;55(4):308\u201313.","journal-title":"Curr Microbiol"},{"issue":"7575","key":"3243_CR161","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/nature15524","volume":"526","author":"S Kommineni","year":"2015","unstructured":"Kommineni S, Bretl DJ, Lam V, Chakraborty R, Hayward M, Simpson P, et al. Bacteriocin production augments niche competition by enterococci in the mammalian gastrointestinal tract. Nature. 2015;526(7575):719\u201322. Available from: https:\/\/www.nature.com\/articles\/nature15524. Cited 2022 Aug 8.","journal-title":"Nature"},{"issue":"4","key":"3243_CR162","first-page":"683","volume":"161","author":"MDC de Freire Bastos","year":"2015","unstructured":"de Freire Bastos MDC, Varella Coelho ML, da Silva Santos OC. Resistance to bacteriocins produced by gram-positive bacteria. Microbiology (United Kingdom). 2015;161(4):683\u2013700. Available from: https:\/\/www.microbiologyresearch.org\/content\/journal\/micro\/10.1099\/mic.0.082289-0. Cited 2022 Aug 9.","journal-title":"Microbiology (United Kingdom)"},{"issue":"5","key":"3243_CR163","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.1128\/AAC.01077-10","volume":"55","author":"KL Blake","year":"2011","unstructured":"Blake KL, Randall CP, O\u2019Neill AJ. In vitro studies indicate a high resistance potential for the lantibiotic nisin in Staphylococcus aureus and define a genetic basis for nisin resistance. Antimicrob Agents Chemother. 2011;55(5):2362\u20138. Available from: https:\/\/journals.asm.org\/doi\/10.1128\/AAC.01077-10. Cited 2022 Aug 9.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"3243_CR164","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/j.1751-7915.2010.00184.x","volume":"3","author":"D Field","year":"2010","unstructured":"Field D, Quigley L, O\u2019Connor PM, Rea MC, Daly K, Cotter PD, et al. Studies with bioengineered Nisin peptides highlight the broad-spectrum potency of Nisin V. Microb Biotechnol. 2010;3(4):473\u201386.","journal-title":"Microb Biotechnol"},{"issue":"3","key":"3243_CR165","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1111\/mmi.14183","volume":"111","author":"D Field","year":"2019","unstructured":"Field D, Blake T, Mathur H, O\u2019Connor PM, Cotter PD, Paul Ross R, et al. Bioengineering nisin to overcome the nisin resistance protein. Mol Microbiol. 2019;111(3):717\u201331.","journal-title":"Mol Microbiol"},{"issue":"5","key":"3243_CR166","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.ijantimicag.2015.07.011","volume":"46","author":"VL Cavera","year":"2015","unstructured":"Cavera VL, Arthur TD, Kashtanov D, Chikindas ML. Bacteriocins and their position in the next wave of conventional antibiotics. Int J Antimicrob Agents. 2015;46(5):494\u2013501.","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"3243_CR167","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1530\/rep.1.00028","volume":"128","author":"KVR Reddy","year":"2004","unstructured":"Reddy KVR, Aranha C, Gupta SM, Yedery RD. Evaluation of antimicrobial peptide nisin as a safe vaginal contraceptive agent in rabbits: in vitro and in vivo studies. Reproduction. 2004;128(1):117\u201326. Available from: https:\/\/rep.bioscientifica.com\/view\/journals\/rep\/128\/1\/1280117.xml. Cited 2022 Aug 9.","journal-title":"Reproduction"},{"issue":"2","key":"3243_CR168","doi-asserted-by":"publisher","first-page":"235","DOI":"10.2217\/fmb.13.148","volume":"9","author":"TD Arthur","year":"2014","unstructured":"Arthur TD, Cavera VL, Chikindas ML. On bacteriocin delivery systems and potential applications. Future Microbiol. 2014;9(2):235\u201348.","journal-title":"Future Microbiol"},{"issue":"2","key":"3243_CR169","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1128\/AEM.01597-09","volume":"76","author":"DJ Birri","year":"2010","unstructured":"Birri DJ, Brede DA, Forberg T, Holo H, Nes IF. Molecular and genetic characterization of a novel bacteriocin locus in Enterococcus avium isolates from infants. Appl Environ Microbiol. 2010;76(2):483\u201392. Available from: https:\/\/journals.asm.org\/doi\/10.1128\/AEM.01597-09. Cited 2022 Nov 15.","journal-title":"Appl Environ Microbiol"},{"issue":"1","key":"3243_CR170","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-70328-z","volume":"10","author":"D Hill","year":"2020","unstructured":"Hill D, O\u2019Connor PM, Altermann E, Day L, Hill C, Stanton C, et al. Extensive bacteriocin gene shuffling in the Streptococcus bovis\/Streptococcus equinus complex reveals gallocin D with activity against vancomycin resistant enterococci. Sci Rep. 2020;10(1):1\u201311. Available from: https:\/\/www.nature.com\/articles\/s41598-020-70328-z. Cited 2022 Oct 12.","journal-title":"Sci Rep"},{"issue":"1","key":"3243_CR171","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-023-34586-x","volume":"13","author":"C O\u2019Reilly","year":"2023","unstructured":"O\u2019Reilly C, Grimaud GM, Coakley M, O\u2019Connor PM, Mathur H, Peterson VL, et al. Modulation of the gut microbiome with nisin. Sci Rep. 2023;13(1):1\u201311. Available from: https:\/\/www.nature.com\/articles\/s41598-023-34586-x. Cited 2023 Oct 7.","journal-title":"Sci Rep"},{"issue":"8","key":"3243_CR172","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1128\/AEM.00096-15","volume":"81","author":"L Khalifa","year":"2015","unstructured":"Khalifa L, Brosh Y, Gelman D, Coppenhagen-Glazer S, Beyth S, Poradosu-Cohen R, et al. Targeting Enterococcus faecalis biofilms with phage therapy. Appl Environ Microbiol. 2015;81(8):2696\u2013705. Available from: https:\/\/journals.asm.org\/doi\/10.1128\/AEM.00096-15. Cited 2023 Oct 7.","journal-title":"Appl Environ Microbiol"},{"key":"3243_CR173","doi-asserted-by":"publisher","first-page":"326","DOI":"10.3389\/fmicb.2018.00326","volume":"9","author":"L Khalifa","year":"2018","unstructured":"Khalifa L, Gelman D, Shlezinger M, Dessal AL, Coppenhagen-Glazer S, Beyth N, et al. Defeating antibiotic- and phage-resistant Enterococcus faecalis using a phage Cocktail in vitro and in a clot model. Front Microbiol. 2018;9:326.","journal-title":"Front Microbiol"},{"issue":"2","key":"3243_CR174","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s00705-020-04905-y","volume":"166","author":"NS Olsen","year":"2021","unstructured":"Olsen NS, Nielsen KJ, Pl\u00f6ger M, Kot W, Hansen LH. Enterococcus phage Nonaheksakonda infecting clinical isolates of Enterococcus faecalis represents a new lineage in the family Siphoviridae. Arch Virol. 2021;166(2):593\u20139.","journal-title":"Arch Virol"},{"issue":"6","key":"3243_CR175","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1080\/17453674.2021.1968714","volume":"92","author":"AS Neuts","year":"2021","unstructured":"Neuts AS, Berkhout HJ, Hartog A, Goosen JHM. Bacteriophage therapy cures a recurrent Enterococcus faecalis infected total hip arthroplasty? A case report. Acta Orthop. 2021;92(6):678. Cited 2023 Oct 7.","journal-title":"Acta Orthop"},{"issue":"4","key":"3243_CR176","doi-asserted-by":"publisher","first-page":"680","DOI":"10.3390\/v13040680","volume":"13","author":"E Murray","year":"2021","unstructured":"Murray E, Draper LA, Ross RP, Hill C. The advantages and challenges of using endolysins in a clinical setting. Viruses. 2021;13(4):680. Available from: https:\/\/www.mdpi.com\/1999-4915\/13\/4\/680\/htm. Cited 2022 Aug 15.","journal-title":"Viruses"},{"issue":"492","key":"3243_CR177","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.virol.2016.02.006","volume":"1","author":"P Gong","year":"2016","unstructured":"Gong P, Cheng M, Li X, Jiang H, Yu C, Kahaer N, et al. Characterization of Enterococcus faecium bacteriophage IME-EFm5 and its endolysin LysEFm5. Virology. 2016;1(492):11\u201320.","journal-title":"Virology"},{"issue":"1","key":"3243_CR178","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12903-022-02434-5","volume":"22","author":"S Shaaban","year":"2022","unstructured":"Shaaban S, Hamad GM, Genena S, Meheissen MA, Moussa S. Evaluation of the antibacterial activity of Lactobacilli probiotics supernatants against Enterococcus faecalis (in-vitro study). BMC Oral Health. 2022;22(1):1\u201311. Available from: https:\/\/bmcoralhealth.biomedcentral.com\/articles\/10.1186\/s12903-022-02434-5. Cited 2023 Oct 7.","journal-title":"BMC Oral Health"},{"issue":"6","key":"3243_CR179","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1111\/iwj.13451","volume":"17","author":"R Knackstedt","year":"2020","unstructured":"Knackstedt R, Knackstedt T, Gatherwright J. The role of topical probiotics on wound healing: A review of animal and human studies. Int Wound J. 2020;17(6):1687\u201394. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1111\/iwj.13451. Cited 2023 Oct 7.","journal-title":"Int Wound J."},{"key":"3243_CR180","unstructured":"Mei L, Zhang D, Shao H, Hao Y, Zhang T, Zheng W, et al. Injectable and self-healing probiotics-loaded hydrogel for promoting superbacteria-infected wound healing. ACS Appl Mater Interfaces. 2021. Available from: https:\/\/pubs.acs.org\/doi\/abs\/10.1021\/acsami.1c23713. Cited 2023 Oct 7."},{"issue":"9","key":"3243_CR181","doi-asserted-by":"publisher","first-page":"454","DOI":"10.5694\/j.1326-5377.2007.tb00995.x","volume":"186","author":"KJ Manley","year":"2007","unstructured":"Manley KJ, Fraenkel MB, Mayall BC, Power DA. Probiotic treatment of vancomycin-resistant enterococci: a randomised controlled trial. Med J Aust. 2007;186(9):454\u20137. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.5694\/j.1326-5377.2007.tb00995.x. Cited 2022 Aug 15.","journal-title":"Med J Aust"},{"issue":"621","key":"3243_CR182","doi-asserted-by":"publisher","first-page":"4692","DOI":"10.1126\/scitranslmed.abf4692","volume":"13","author":"P Piewngam","year":"2021","unstructured":"Piewngam P, Chiou J, Ling J, Liu R, Pupa P, Zheng Y, et al. Enterococcal bacteremia in mice is prevented by oral administration of probiotic Bacillus spores. Sci Transl Med. 2021;13(621):4692. Available from: https:\/\/www.science.org\/doi\/10.1126\/scitranslmed.abf4692. Cited 2023 Oct 7.","journal-title":"Sci Transl Med"},{"issue":"7","key":"3243_CR183","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1128\/JCM.00473-10","volume":"48","author":"M Vidal","year":"2010","unstructured":"Vidal M, Forestier C, Charbonnel N, Henard S, Rabaud C, Lesens O. Probiotics and intestinal colonization by vancomycin-resistant enterococci in mice and humans. J Clin Microbiol. 2010;48(7):2595\u20138.","journal-title":"J Clin Microbiol"},{"issue":"8","key":"3243_CR184","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1093\/femsle\/fnv012","volume":"362","author":"L Crouzet","year":"2015","unstructured":"Crouzet L, Rigottier-Gois L, Serror P. Potential use of probiotic and commensal bacteria as non-antibiotic strategies against vancomycin-resistant enterococci. FEMS Microbiol Lett. 2015;362(8):12. Available from: https:\/\/academic.oup.com\/femsle\/article\/362\/8\/fnv012\/2467468. Cited 2022 Aug 15.","journal-title":"FEMS Microbiol Lett"},{"key":"3243_CR185","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1111\/jam.13033","volume":"120","author":"JM Shin","year":"2016","unstructured":"Shin JM, Gwak JW, Kamarajan P, Fenno JC, Rickard AH, Kapila YL. Biomedical applications of nisin. J Appl Microbiol. 2016;120:1449\u201365. Blackwell Publishing Ltd.","journal-title":"J Appl Microbiol"},{"key":"3243_CR186","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.tim.2011.11.001","volume":"20","author":"FL Paganelli","year":"2011","unstructured":"Paganelli FL, Willems RJ, Leavis HL. Optimizing future treatment of enterococcal infections: attacking the biofilm? Trends Microbiol. 2011;20:40\u20139.","journal-title":"Trends Microbiol"},{"issue":"6","key":"3243_CR187","doi-asserted-by":"publisher","first-page":"e1006990","DOI":"10.1371\/journal.ppat.1006990","volume":"14","author":"E Pursey","year":"2018","unstructured":"Pursey E, S\u00fcnderhauf D, Gaze WH, Westra ER, van Houte S. CRISPR-Cas antimicrobials: Challenges and future prospects. PLoS Pathog. 2018;14(6):e1006990. Available from: https:\/\/journals.plos.org\/plospathogens\/article?id=10.1371\/journal.ppat.1006990. Cited 2022 Aug 16.","journal-title":"PLoS Pathog"},{"issue":"6","key":"3243_CR188","doi-asserted-by":"publisher","first-page":"711","DOI":"10.2217\/fmb-2017-0261","volume":"13","author":"C Hill","year":"2018","unstructured":"Hill C, Mills S, Ross RP. Phages & antibiotic resistance: Are the most abundant entities on earth ready for a comeback? Future Microbiol. 2018;13(6):711\u201326. Available from: https:\/\/www.futuremedicine.com\/doi\/10.2217\/fmb-2017-0261. Cited 2022 Aug 9.","journal-title":"Future Microbiol"},{"issue":"2","key":"3243_CR189","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3855\/jidc.3573","volume":"8","author":"Z Golkar","year":"2014","unstructured":"Golkar Z, Bagasra O, Gene Pace D. Bacteriophage therapy: a potential solution for the antibiotic resistance crisis. J Infect Dev Ctries. 2014;8(2):129\u201336. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/24518621\/. Cited 2022 Aug 9.","journal-title":"J Infect Dev Ctries"},{"issue":"2","key":"3243_CR190","doi-asserted-by":"publisher","first-page":"111","DOI":"10.4161\/bact.1.2.14590","volume":"1","author":"C Loc-Carrillo","year":"2011","unstructured":"Loc-Carrillo C, Abedon ST. Pros and cons of phage therapy. Bacteriophage. 2011;1(2):111.","journal-title":"Bacteriophage"},{"issue":"17","key":"3243_CR191","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms21176345","volume":"21","author":"G Topka-Bielecka","year":"2020","unstructured":"Topka-Bielecka G, Bloch S, Nejman-Fale\u0144czyk B, Grabski M, Jurczak-Kurek A, G\u00f3rniak M, et al. Characterization of the Bacteriophage vB_EfaS-271 Infecting Enterococcus faecalis. Int J Mol Sci. 2020;21(17):1\u201327. Cited 2022 Aug 15.","journal-title":"Int J Mol Sci"},{"key":"3243_CR192","first-page":"298","volume":"1","author":"A Soleimani-Delfan","year":"2021","unstructured":"Soleimani-Delfan A, Bouzari M, Wang R. vB_EfaS-DELF1, a novel Siphoviridae bacteriophage with highly effective lytic activity against vancomycin-resistant Enterococcus faecalis. Virus Res. 2021;1:298.","journal-title":"Virus Res"},{"issue":"1","key":"3243_CR193","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1128\/IAI.70.1.204-210.2002","volume":"70","author":"B Biswas","year":"2002","unstructured":"Biswas B, Adhya S, Washart P, Paul B, Trostel AN, Powell B, et al. Bacteriophage therapy rescues mice bacteremic from a clinical isolate of vancomycin-resistant Enterococcus faecium. Infect Immun. 2002;70(1):204\u201310.","journal-title":"Infect Immun"},{"issue":"MAY","key":"3243_CR194","doi-asserted-by":"publisher","first-page":"837","DOI":"10.3389\/fmicb.2017.00837","volume":"8","author":"M Cheng","year":"2017","unstructured":"Cheng M, Liang J, Zhang Y, Hu L, Gong P, Cai R, et al. The bacteriophage EF-P29 efficiently protects against lethal vancomycin-resistant enterococcus faecalis and alleviates gut microbiota imbalance in a murine bacteremia model. Front Microbiol. 2017;8(MAY):837.","journal-title":"Front Microbiol"},{"issue":"4","key":"3243_CR195","doi-asserted-by":"publisher","first-page":"e01304","DOI":"10.1128\/mBio.01304-16","volume":"7","author":"BA Duerkop","year":"2016","unstructured":"Duerkop BA, Huo W, Bhardwaj P, Palmer KL, Hooper LV. Molecular Basis for Lytic Bacteriophage Resistance in Enterococci. mBio. 2016;7(4):e01304\u201316. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/27578757\/. Cited 2022 Aug 9.","journal-title":"mBio"},{"issue":"9","key":"3243_CR196","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.resmic.2018.04.008","volume":"169","author":"D Gelman","year":"2018","unstructured":"Gelman D, Beyth S, Lerer V, Adler K, Poradosu-Cohen R, Coppenhagen-Glazer S, et al. Combined bacteriophages and antibiotics as an efficient therapy against VRE Enterococcus faecalis in a mouse model. Res Microbiol. 2018;169(9):531\u20139.","journal-title":"Res Microbiol"},{"issue":"2","key":"3243_CR197","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.tim.2008.11.002","volume":"17","author":"RM Donlan","year":"2009","unstructured":"Donlan RM. Preventing biofilms of clinically relevant organisms using bacteriophage. Trends Microbiol. 2009;17(2):66\u201372. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/19162482\/. Cited 2022 Aug 15.","journal-title":"Trends Microbiol"},{"issue":"8","key":"3243_CR198","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1128\/AEM.00096-15","volume":"81","author":"L Khalifa","year":"2015","unstructured":"Khalifa L, Brosh Y, Gelman D, Coppenhagen-Glazer S, Beyth S, Poradosu-Cohen R, et al. Targeting Enterococcus faecalis biofilms with phage therapy. Appl Environ Microbiol. 2015;81(8):2696\u2013705. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/25662974\/. Cited 2022 Aug 15.","journal-title":"Appl Environ Microbiol"},{"key":"3243_CR199","doi-asserted-by":"publisher","unstructured":"Gelman D, Beyth S, Lerer V, Adler K, Poradosu-Cohen R, Coppenhagen-Glazer S, et al. Combined bacteriophages and antibiotics as an efficient therapy against VRE Enterococcus faecalis in a mouse model. Res Microbiol. 2018;169(9):531\u20139. https:\/\/doi.org\/10.1016\/j.resmic.2018.04.008.","DOI":"10.1016\/j.resmic.2018.04.008"},{"key":"3243_CR200","doi-asserted-by":"crossref","unstructured":"Canfield GS, Chatterjee A, Espinosa J, Mangalea MR, Sheriff EK, Keidan M, et al. Lytic bacteriophages facilitate antibiotic sensitization of Enterococcus faecium. Antimicrob Agents Chemother. 2021;65(5). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33649110\/. Cited 2022 Aug 15.","DOI":"10.1128\/AAC.00143-21"},{"key":"3243_CR201","doi-asserted-by":"crossref","unstructured":"Paul K, Merabishvili M, Hazan R, Christner M, Herden U, Gelman D, et al. Bacteriophage Rescue Therapy of a Vancomycin-Resistant Enterococcus faecium Infection in a One-Year-Old Child following a Third Liver Transplantation. Viruses. 2021;13(9):1785. Available from: https:\/\/www.mdpi.com\/1999-4915\/13\/9\/1785\/htm. Cited 2022 Aug 10.","DOI":"10.3390\/v13091785"},{"key":"3243_CR202","doi-asserted-by":"crossref","unstructured":"Zhang H, Fouts DE, DePew J, Stevens RH. Genetic modifications to temperate Enterococcus faecalis phage \u03d5Ef11 that abolish the establishment of lysogeny and sensitivity to repressor, and increase host range and productivity of lytic infection. Microbiology (N Y). 2013;159(Pt 6):1023. Cited 2023 Oct 16.","DOI":"10.1099\/mic.0.067116-0"},{"issue":"5","key":"3243_CR203","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.tibtech.2022.08.008","volume":"41","author":"M Mahler","year":"2023","unstructured":"Mahler M, Costa AR, van Beljouw SPB, Fineran PC, Brouns SJJ. Approaches for bacteriophage genome engineering. Trends Biotechnol. 2023;41(5):669\u201385. Available from: http:\/\/www.cell.com\/article\/S0167779922002268\/fulltext. Cited 2023 Oct 16.","journal-title":"Trends Biotechnol"},{"key":"3243_CR204","doi-asserted-by":"crossref","unstructured":"Mitsunaka S, Yamazaki K, Pramono AK, Ikeuchi M, Kitao T, Ohara N, et al. Synthetic engineering and biological containment of bacteriophages. Proc Natl Acad Sci U S A. 2022;119(48). Cited 2023 Oct 16.","DOI":"10.1073\/pnas.2206739119"},{"key":"3243_CR205","doi-asserted-by":"publisher","unstructured":"Hesse S, Adhya S. Phage Therapy in the Twenty-First Century: Facing the Decline of the Antibiotic Era; Is It Finally Time for the Age of the Phage? 2019;73:155\u201374. Available from: https:\/\/doi.org\/10.1146\/annurev-micro-090817-062535, https:\/\/www.annualreviews.org\/doi\/abs\/10.1146\/annurev-micro-090817-062535. Cited 2023 Oct 16.","DOI":"10.1146\/annurev-micro-090817-062535"},{"issue":"4","key":"3243_CR206","doi-asserted-by":"publisher","first-page":"104121","DOI":"10.1016\/j.isci.2022.104121","volume":"25","author":"VK Mutalik","year":"2022","unstructured":"Mutalik VK, Arkin AP. A phage foundry framework to systematically develop viral countermeasures to combat antibiotic-resistant bacterial pathogens. iScience. 2022;25(4):104121. Cited 2023 Oct 16.","journal-title":"iScience"},{"issue":"MAY","key":"3243_CR207","first-page":"373342","volume":"9","author":"I Fern\u00e1ndez-Ruiz","year":"2018","unstructured":"Fern\u00e1ndez-Ruiz I, Coutinho FH, Rodriguez-Valera F. Thousands of novel endolysins discovered in uncultured phage genomes. Front Microbiol. 2018;9(MAY):373342.","journal-title":"Front Microbiol"},{"issue":"1","key":"3243_CR208","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-45441-3","volume":"9","author":"C Archambaud","year":"2019","unstructured":"Archambaud C, Derr\u00e9-Bobillot A, Lapaque N, Rigottier-Gois L, Serror P. Intestinal translocation of enterococci requires a threshold level of enterococcal overgrowth in the lumen. Sci Rep. 2019;9(1):1\u201312. Available from: https:\/\/www.nature.com\/articles\/s41598-019-45441-3. Cited 2022 Aug 4.","journal-title":"Sci Rep"},{"issue":"5","key":"3243_CR209","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1586\/14787210.6.5.637","volume":"6","author":"CA Arias","year":"2008","unstructured":"Arias CA, Murray BE. Emergence and management of drug-resistant enterococcal infections. Expert Rev Anti Infect Ther. 2008;6(5):637\u201355. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/18847403\/. Cited 2022 Aug 4.","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"7214","key":"3243_CR210","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1038\/nature07250","volume":"455","author":"K Brandl","year":"2008","unstructured":"Brandl K, Plitas G, Mihu CN, Ubeda C, Jia T, Fleisher M, et al. Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits. Nature. 2008;455(7214):804\u20137.","journal-title":"Nature"},{"issue":"1","key":"3243_CR211","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s40168-018-0483-7","volume":"6","author":"C Panebianco","year":"2018","unstructured":"Panebianco C, Andriulli A, Pazienza V. Pharmacomicrobiomics: exploiting the drug-microbiota interactions in anticancer therapies. Microbiome. 2018;6(1):92. Available from: https:\/\/microbiomejournal.biomedcentral.com\/articles\/10.1186\/s40168-018-0483-7. Cited 2022 Aug 7.","journal-title":"Microbiome"},{"issue":"2","key":"3243_CR212","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1086\/599346","volume":"49","author":"MJ van Vliet","year":"2009","unstructured":"van Vliet MJ, Tissing WJE, Dun CAJ, Meessen NEL, Kamps WA, de Bont ESJM, et al. Chemotherapy treatment in pediatric patients with acute myeloid leukemia receiving antimicrobial prophylaxis leads to a relative increase of colonization with potentially pathogenic bacteria in the gut. Clin Infect Dis. 2009;49(2):262\u201370. Available from: https:\/\/academic.oup.com\/cid\/article\/49\/2\/262\/404704. Cited 2022 Aug 7.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"3243_CR213","doi-asserted-by":"publisher","first-page":"e2020009","DOI":"10.4084\/mjhid.2020.009","volume":"12","author":"BA Hansen","year":"2020","unstructured":"Hansen BA, Wendelbo \u00d8, Bruserud \u00d8, Hemsing AL, Mosevoll KA, Reikvam H. Febrile neutropenia in acute leukemia. Epidemiology, etiology, pathophysiology and treatment. Mediterr J Hematol Infect Dis. 2020;12(1):e2020009\u2013e2020009. Available from: https:\/\/mjhid.org\/index.php\/mjhid\/article\/view\/2020.009\/3735. Cited 2022 Aug 7.","journal-title":"Mediterr J Hematol Infect Dis"},{"issue":"1","key":"3243_CR214","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-45441-3","volume":"9","author":"C Archambaud","year":"2019","unstructured":"Archambaud C, Derr\u00e9-Bobillot A, Lapaque N, Rigottier-Gois L, Serror P. Intestinal translocation of enterococci requires a threshold level of enterococcal overgrowth in the lumen. Sci Rep. 2019;9(1):1\u201312.","journal-title":"Sci Rep"},{"issue":"12","key":"3243_CR215","doi-asserted-by":"publisher","first-page":"4332","DOI":"10.1172\/JCI43918","volume":"120","author":"C Ubeda","year":"2010","unstructured":"Ubeda C, Taur Y, Jenq RR, Equinda MJ, Son T, Samstein M, et al. Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans. J Clin Invest. 2010;120(12):4332\u201341.","journal-title":"J Clin Invest"},{"issue":"6285","key":"3243_CR216","first-page":"535","volume":"352","author":"EG Pamer","year":"2016","unstructured":"Pamer EG. Resurrecting the intestinal microbiota to combat antibiotic-resistant pathogens. Science (1979). 2016;352(6285):535\u20138. Available from: https:\/\/www.science.org\/doi\/10.1126\/science.aad9382. Cited 2022 Aug 15.","journal-title":"Science (1979)"},{"issue":"1","key":"3243_CR217","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-23437-9","volume":"8","author":"L Crouzet","year":"2018","unstructured":"Crouzet L, Derrien M, Cherbuy C, Plancade S, Foulon M, Chalin B, et al. Lactobacillus paracasei CNCM I-3689 reduces vancomycin-resistant Enterococcus persistence and promotes Bacteroidetes resilience in the gut following antibiotic challenge. Sci Rep. 2018;8(1):1\u201311. Available from: https:\/\/www.nature.com\/articles\/s41598-018-23437-9. Cited 2022 Aug 15.","journal-title":"Sci Rep"},{"issue":"6","key":"3243_CR218","doi-asserted-by":"publisher","first-page":"e00537","DOI":"10.1128\/mSphere.00537-20","volume":"5","author":"R Chanderraj","year":"2020","unstructured":"Chanderraj R, Brown CA, Hinkle K, Falkowski N, Ranjan P, Dickson RP, et al. Gut Microbiota Predict Enterococcus Expansion but Not Vancomycin-Resistant Enterococcus Acquisition. mSphere. 2020;5(6):e00537\u201320.","journal-title":"mSphere"},{"issue":"2","key":"3243_CR219","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nrgastro.2011.244","volume":"9","author":"TJ Borody","year":"2011","unstructured":"Borody TJ, Khoruts A. Fecal microbiota transplantation and emerging applications. Nat Rev Gastroenterol Hepatol. 2011;9(2):88\u201396. Available from: https:\/\/www.nature.com\/articles\/nrgastro.2011.244. Cited 2022 Aug 15.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"3243_CR220","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13756-022-01064-4","volume":"11","author":"JH Hyun","year":"2022","unstructured":"Hyun JH, Lee SK, Cheon JH, Yong DE, Koh H, Kang YK, et al. Faecal microbiota transplantation reduces amounts of antibiotic resistance genes in patients with multidrug-resistant organisms. Antimicrob Resist Infect Control. 2022;11(1):1\u20138. Available from: https:\/\/aricjournal.biomedcentral.com\/articles\/10.1186\/s13756-022-01064-4. Cited 2022 Aug 15.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"3","key":"3243_CR221","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1128\/IAI.01197-12","volume":"81","author":"C Ubeda","year":"2013","unstructured":"Ubeda C, Bucci V, Caballero S, Djukovic A, Toussaint NC, Equinda M, et al. Intestinal microbiota containing Barnesiella species cures vancomycin-resistant Enterococcus faecium colonization. Infect Immun. 2013;81(3):965\u201373. Available from: https:\/\/journals.asm.org\/doi\/10.1128\/IAI.01197-12. Cited 2022 Aug 15.","journal-title":"Infect Immun"},{"issue":"9","key":"3243_CR222","doi-asserted-by":"publisher","first-page":"e1005132","DOI":"10.1371\/journal.ppat.1005132","volume":"11","author":"S Caballero","year":"2015","unstructured":"Caballero S, Carter R, Ke X, Su\u0161ac B, Leiner IM, Kim GJ, et al. Distinct but spatially overlapping intestinal niches for vancomycin-resistant enterococcus faecium and Carbapenem-Resistant Klebsiella pneumoniae. PLoS Pathog. 2015;11(9):e1005132. Available from: https:\/\/journals.plos.org\/plospathogens\/article?id=10.1371\/journal.ppat.1005132. Cited 2022 Aug 15.","journal-title":"PLoS Pathog"},{"issue":"1","key":"3243_CR223","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40168-018-0549-6","volume":"6","author":"C Staley","year":"2018","unstructured":"Staley C, Kaiser T, Vaughn BP, Graiziger CT, Hamilton MJ, Rehman TU, et al. Predicting recurrence of Clostridium difficile infection following encapsulated fecal microbiota transplantation. Microbiome. 2018;6(1):1\u201313. Available from: https:\/\/microbiomejournal.biomedcentral.com\/articles\/10.1186\/s40168-018-0549-6. Cited 2023 Oct 16.","journal-title":"Microbiome"},{"issue":"9","key":"3243_CR224","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1038\/s41591-022-01991-0","volume":"28","author":"A Lavelle","year":"2022","unstructured":"Lavelle A, Sokol H. Understanding and predicting the efficacy of FMT. Nature Medicine. 2022;28(9):1759\u201360. Available from: https:\/\/www.nature.com\/articles\/s41591-022-01991-0. Cited 2023 Oct 16.","journal-title":"Nature Medicine"},{"key":"3243_CR225","doi-asserted-by":"publisher","unstructured":"Gaca AO, Gilmore MS. Killing of VRE Enterococcus faecalis by commensal strains: Evidence for evolution and accumulation of mobile elements in the absence of competition. 2016;7(1):90\u20136. Available from: https:\/\/doi.org\/10.1080\/1949097620151127482, https:\/\/www.tandfonline.com\/doi\/abs\/10.1080\/19490976.2015.1127482. Cited 2022 Aug 15.","DOI":"10.1080\/1949097620151127482"},{"issue":"1","key":"3243_CR226","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-022-35380-5","volume":"13","author":"S Isaac","year":"2022","unstructured":"Isaac S, Flor-Duro A, Carruana G, Puchades-Carrasco L, Quirant A, Lopez-Nogueroles M, et al. Microbiome-mediated fructose depletion restricts murine gut colonization by vancomycin-resistant Enterococcus. Nat Commun. 2022;13(1):1\u201319. Available from: https:\/\/www.nature.com\/articles\/s41467-022-35380-5. Cited 2023 Oct 5.","journal-title":"Nat Commun"},{"issue":"9","key":"3243_CR227","doi-asserted-by":"publisher","first-page":"100576","DOI":"10.1016\/j.crmeth.2023.100576","volume":"3","author":"S Ke","year":"2023","unstructured":"Ke S, Xiao Y, Weiss ST, Chen X, Kelly CP, Liu YY. A computational method to dissect colonization resistance of the gut microbiota against pathogens. Cell Reports Methods. 2023;3(9):100576.","journal-title":"Cell Reports Methods"},{"issue":"8","key":"3243_CR228","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/nrgastro.2014.66","volume":"11","author":"C Hill","year":"2014","unstructured":"Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, et al. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014;11(8):506\u201314. Available from: https:\/\/www.nature.com\/articles\/nrgastro.2014.66. Cited 2022 Aug 15.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"3243_CR229","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.medmal.2013.10.002","volume":"44","author":"MJ Butel","year":"2014","unstructured":"Butel MJ. Probiotics, gut microbiota and health. Med Mal Infect. 2014;44(1):1\u20138. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/24290962\/. Cited 2022 Aug 15.","journal-title":"Med Mal Infect"},{"issue":"18","key":"3243_CR230","doi-asserted-by":"publisher","first-page":"7617","DOI":"10.1073\/pnas.0700440104","volume":"104","author":"SC Corr","year":"2007","unstructured":"Corr SC, Li Y, Riedel CU, O\u2019Toole PW, Hill C, Gahan CGM. Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118. Proc Natl Acad Sci U S A. 2007;104(18):7617\u201321. Available from: https:\/\/www.pnas.org\/cgi\/content\/full\/. Cited 2023 Oct 10.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"3243_CR231","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1046\/j.1472-765X.2001.00948.x","volume":"33","author":"CJ Donskey","year":"2001","unstructured":"Donskey CJ, Hoyen CK, Das SM, Farmer S, Dery M, Bonomo RA. Effect of oral Bacillus coagulans administration on the density of vancomycin-resistant enterococci in the stool of colonized mice. Lett Appl Microbiol. 2001;33(1):84\u20138. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1046\/j.1472-765X.2001.00948.x. Cited 2022 Aug 15.","journal-title":"Lett Appl Microbiol"},{"issue":"2","key":"3243_CR232","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1093\/ps\/85.2.273","volume":"85","author":"Y Sakai","year":"2006","unstructured":"Sakai Y, Tsukahara T, Bukawa W, Matsubara N, Ushida K. Cell preparation of Enterococcus faecalis strain EC-12 prevents vancomycin-resistant enterococci colonization in the cecum of newly hatched chicks. Poult Sci. 2006;85(2):273\u20137. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/16523627\/. Cited 2022 Aug 15.","journal-title":"Poult Sci"},{"issue":"10","key":"3243_CR233","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1097\/MCG.0b013e318227439f","volume":"45","author":"P Szachta","year":"2011","unstructured":"Szachta P, Igny\u015b I, Cichy W. An evaluation of the ability of the probiotic strain Lactobacillus rhamnosus GG to eliminate the gastrointestinal carrier state of vancomycin-resistant enterococci in colonized children. J Clin Gastroenterol. 2011;45(10):872\u20137. Available from: https:\/\/journals.lww.com\/jcge\/Fulltext\/2011\/11000\/An_Evaluation_of_the_Ability_of_the_Probiotic.10.aspx. Cited 2022 Aug 15.","journal-title":"J Clin Gastroenterol"},{"issue":"8","key":"3243_CR234","doi-asserted-by":"publisher","first-page":"4593","DOI":"10.1128\/AAC.00300-15","volume":"59","author":"S Doron","year":"2015","unstructured":"Doron S, Hibberd PL, Goldin B, Thorpe C, McDermott L, Snydman DR. Effect of Lactobacillus rhamnosus GG administration on vancomycin-resistant Enterococcus colonization in adults with comorbidities. Antimicrob Agents Chemother. 2015;59(8):4593\u20139. Available from: https:\/\/journals.asm.org\/doi\/10.1128\/AAC.00300-15. Cited 2022 Aug 15.","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"3243_CR235","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.1128\/AAC.01765-09","volume":"54","author":"MJA De Regt","year":"2010","unstructured":"De Regt MJA, Willems RJL, Hen\u00e9 RJ, Siersema PD, Verhaar HJJ, Hopmans TEM, et al. Effects of probiotics on acquisition and spread of multiresistant enterococci. Antimicrob Agents Chemother. 2010;54(7):2801\u20135. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/20404120\/. Cited 2023 Oct 10.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"3243_CR236","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13054-016-1434-y","volume":"20","author":"W Manzanares","year":"2016","unstructured":"Manzanares W, Lemieux M, Langlois PL, Wischmeyer PE. Probiotic and synbiotic therapy in critical illness: A systematic review and meta-analysis. Crit Care. 2016;20(1):1\u201319. Available from: https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-016-1434-y. Cited 2023 Oct 10.","journal-title":"Crit Care"},{"issue":"6","key":"3243_CR237","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.cell.2018.08.041","volume":"174","author":"N Zmora","year":"2018","unstructured":"Zmora N, Zilberman-Schapira G, Suez J, Mor U, Dori-Bachash M, Bashiardes S, et al. Personalized gut mucosal colonization resistance to empiric probiotics is associated with unique host and microbiome features. Cell. 2018;174(6):1388\u20131405.e21. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/30193112\/. Cited 2023 Oct 16.","journal-title":"Cell"},{"issue":"1","key":"3243_CR238","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1080\/19490976.2019.1586039","volume":"11","author":"J Suez","year":"2020","unstructured":"Suez J, Zmora N, Elinav E. Probiotics in the next-generation sequencing era. Gut Microbes. 2020;11(1):77\u201393. Available from: https:\/\/www.tandfonline.com\/doi\/abs\/10.1080\/19490976.2019.1586039. Cited 2023 Oct 16.","journal-title":"Gut Microbes"},{"key":"3243_CR239","unstructured":"Maldonado-G\u00f3mez M, Mart\u00ednez I, \u2026 FBC host &, 2016 undefined. Stable engraftment of Bifidobacterium longum AH1206 in the human gut depends on individualized features of the resident microbiome. cell.comMX Maldonado-G\u00f3mez, I Mart\u00ednez, F Bottacini, A O\u2019Callaghan, M Ventura, D van SinderenCell host & microbe, 2016\u2022cell.com. Available from: https:\/\/www.cell.com\/cell-host-microbe\/pdf\/S1931-3128(16)30378-X.pdf. Cited 2023 Oct 16."},{"key":"3243_CR240","doi-asserted-by":"publisher","unstructured":"Sun Y, Li H, Zheng L, Li J, Hong Y, Liang P, et al. iProbiotics: a machine learning platform for rapid identification of probiotic properties from whole-genome primary sequences. Brief Bioinform. 2022;23(1). Available from: https:\/\/doi.org\/10.1093\/bib\/bbab477. Cited 2023 Oct 16.","DOI":"10.1093\/bib\/bbab477"},{"issue":"5","key":"3243_CR241","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41579-020-00506-3","volume":"19","author":"F Micoli","year":"2021","unstructured":"Micoli F, Bagnoli F, Rappuoli R, Serruto D. The role of vaccines in combatting antimicrobial resistance. Nat Rev Microbiol. 2021;19(5):287\u2013302. Available from: https:\/\/www.nature.com\/articles\/s41579-020-00506-3. Cited 2023 Oct 2.","journal-title":"Nat Rev Microbiol"},{"key":"3243_CR242","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1472-6750-6-35","volume":"6","author":"S Vivona","year":"2006","unstructured":"Vivona S, Bernante F, Filippini F. NERVE: New enhanced reverse vaccinology environment. BMC Biotechnol. 2006;6:35. Cited 2023 Oct 16.","journal-title":"BMC Biotechnol"},{"issue":"45","key":"3243_CR243","doi-asserted-by":"publisher","first-page":"8156","DOI":"10.1016\/j.vaccine.2011.07.142","volume":"29","author":"BN Bowman","year":"2011","unstructured":"Bowman BN, McAdam PR, Vivona S, Zhang JX, Luong T, Belew RK, et al. Improving reverse vaccinology with a machine learning approach. Vaccine. 2011;29(45):8156\u201364.","journal-title":"Vaccine"},{"issue":"5731","key":"3243_CR244","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1126\/science.1109869","volume":"309","author":"D Maione","year":"2005","unstructured":"Maione D, Margarit I, Rinaudo CD, Masignani V, Mora M, Scarselli M, et al. Immunology: Identification of a universal group B Streptococcus vaccine by multiple genome screen. Science. 2005;309(5731):148\u201350. Available from: https:\/\/www.science.org\/doi\/10.1126\/science.1109869. Cited 2023 Oct 3.","journal-title":"Science"},{"key":"3243_CR245","doi-asserted-by":"publisher","first-page":"3245","DOI":"10.1016\/j.vaccine.2009.01.072","volume":"27","author":"D Serruto","year":"2009","unstructured":"Serruto D, Serino L, Masignani V, Pizza M. Genome-based approaches to develop vaccines against bacterial pathogens. Vaccine. 2009;27:3245\u201350. Available from: http:\/\/www.genomesonline.org\/. Cited 2023 Oct 2.","journal-title":"Vaccine"},{"issue":"1","key":"3243_CR246","doi-asserted-by":"publisher","first-page":"e1000716","DOI":"10.1371\/journal.ppat.1000716","volume":"6","author":"KV Singh","year":"2010","unstructured":"Singh KV, Nallapareddy SR, Sillanp\u00e4\u00e4 J, Murray BE. Importance of the Collagen Adhesin Ace in Pathogenesis and Protection against Enterococcus faecalis Experimental Endocarditis. PLoS Pathog. 2010;6(1):e1000716. Available from: https:\/\/journals.plos.org\/plospathogens\/article?id=10.1371\/journal.ppat.1000716. Cited 2023 Oct 3.","journal-title":"PLoS Pathog"},{"issue":"11","key":"3243_CR247","doi-asserted-by":"publisher","first-page":"e111880","DOI":"10.1371\/journal.pone.0111880","volume":"9","author":"F Romero-Saavedra","year":"2014","unstructured":"Romero-Saavedra F, Laverde D, Wobser D, Michaux C, Budin-Verneuil A, Bernay B, et al. Identification of Peptidoglycan-Associated Proteins as Vaccine Candidates for Enterococcal Infections. PLoS One. 2014;9(11):e111880. Available from: https:\/\/journals.plos.org\/plosone\/article?id=10.1371\/journal.pone.0111880. Cited 2023 Oct 3.","journal-title":"PLoS One"},{"issue":"12","key":"3243_CR248","first-page":"3429","volume":"157","author":"A Kropec","year":"2011","unstructured":"Kropec A, Sava IG, Vonend C, Sakinc T, Grohmann E, Huebner J. Identification of SagA as a novel vaccine target for the prevention of Enterococcus faecium infections. Microbiology (N Y). 2011;157(12):3429\u201334. Available from: https:\/\/www.microbiologyresearch.org\/content\/journal\/micro\/10.1099\/mic.0.053207-0. Cited 2023 Oct 3.","journal-title":"Microbiology (N Y)."},{"issue":"5","key":"3243_CR249","first-page":"344","volume":"23","author":"H Kazemian","year":"2019","unstructured":"Kazemian H, Pourmand MR, Siadat SD, Mahdavi M, Yazdi MH, Majelan PA, et al. Molecular Cloning and Immunogenicity Evaluation of PpiC, GelE, and VS87_01105 Proteins of Enterococcus faecalis as Vaccine Candidates. Iran Biomed J. 2019;23(5):344. Cited 2023 Oct 3.","journal-title":"Iran Biomed J."},{"issue":"8","key":"3243_CR250","doi-asserted-by":"publisher","first-page":"4631","DOI":"10.1128\/IAI.68.8.4631-4636.2000","volume":"68","author":"J Huebner","year":"2000","unstructured":"Huebner J, Quaas A, Krueger WA, Goldmann DA, Pier GB. Prophylactic and therapeutic efficacy of antibodies to a capsular polysaccharide shared among vancomycin-sensitive and -resistant enterococci. Infect Immun. 2000;68(8):4631\u20136. Available from: https:\/\/journals.asm.org\/doi\/10.1128\/iai.68.8.4631-4636.2000. Cited 2023 Oct 3.","journal-title":"Infect Immun"},{"key":"3243_CR251","doi-asserted-by":"crossref","unstructured":"AbdelKhalek A, Abutaleb NS, Elmagarmid KA, Seleem MN. Repurposing auranofin as an intestinal decolonizing agent for vancomycin-resistant enterococci. Sci Rep. 2018;8(1). Cited 2022 Aug 8.","DOI":"10.1038\/s41598-018-26674-0"},{"issue":"1","key":"3243_CR252","doi-asserted-by":"publisher","first-page":"100005","DOI":"10.1016\/j.xcrm.2020.100005","volume":"1","author":"M Garland","year":"2020","unstructured":"Garland M, Hryckowian AJ, Tholen M, Oresic Bender K, van Treuren WW, Loscher S, et al. The clinical drug ebselen attenuates inflammation and promotes microbiome recovery in mice after antibiotic treatment for CDI. Cell Rep Med. 2020;1(1):100005. Cited 2022 Aug 8.","journal-title":"Cell Rep Med"},{"key":"3243_CR253","doi-asserted-by":"crossref","unstructured":"Marreddy RKR, Olaitan AO, May JN, Dong M, Hurdle JG. Ebselen Not Only Inhibits Clostridioides difficile Toxins but Displays Redox-Associated Cellular Killing. Microbiol Spectr. 2021;9(2). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34468187\/. Cited 2022 Aug 8.","DOI":"10.1128\/Spectrum.00448-21"},{"issue":"3","key":"3243_CR254","doi-asserted-by":"publisher","first-page":"105828","DOI":"10.1016\/j.ijantimicag.2019.10.009","volume":"55","author":"NS Abutaleb","year":"2020","unstructured":"Abutaleb NS, Seleem MN. Antivirulence activity of auranofin against vancomycin-resistant enterococci: in vitro and in vivo studies. Int J Antimicrob Agents. 2020;55(3):105828.","journal-title":"Int J Antimicrob Agents"},{"issue":"7698","key":"3243_CR255","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/nature25979","volume":"555","author":"L Maier","year":"2018","unstructured":"Maier L, Pruteanu M, Kuhn M, Zeller G, Telzerow A, Anderson EE, et al. Extensive impact of non-antibiotic drugs on human gut bacteria. Nature. 2018;555(7698):623\u20138. Available from: https:\/\/www.nature.com\/articles\/nature25979.Cited 2022 Aug 8.","journal-title":"Nature"},{"issue":"1","key":"3243_CR256","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-64882-9","volume":"10","author":"NS Abutaleb","year":"2020","unstructured":"Abutaleb NS, Seleem MN. Auranofin, at clinically achievable dose, protects mice and prevents recurrence from Clostridioides difficile infection. Sci Rep. 2020;10(1):1\u20138. Available from: https:\/\/www.nature.com\/articles\/s41598-020-64882-9. Cited 2022 Aug 8.","journal-title":"Sci Rep"},{"key":"3243_CR257","first-page":"1","volume":"32","author":"MW Mullowney","year":"2023","unstructured":"Mullowney MW, Duncan KR, Elsayed SS, Garg N, van der Hooft JJJ, Martin NI, et al. Artificial intelligence for natural product drug discovery. Nat Rev Drug Discov. 2023;32:1\u201322. Available from: https:\/\/www.nature.com\/articles\/s41573-023-00774-7. Cited 2023 Oct 16.","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"3243_CR258","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/d41573-022-00025-1","volume":"21","author":"MKP Jayatunga","year":"2022","unstructured":"Jayatunga MKP, Xie W, Ruder L, Schulze U, Meier C. AI in small-molecule drug discovery: a coming wave? Nat Rev Drug Discov. 2022;21(3):175\u20136.","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"3243_CR259","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/s41596-021-00659-2","volume":"17","author":"F Gentile","year":"2022","unstructured":"Gentile F, Yaacoub JC, Gleave J, Fernandez M, Ton AT, Ban F, et al. Artificial intelligence\u2013enabled virtual screening of ultra-large chemical libraries with deep docking. Nature Protocols. 2022;17(3):672\u201397. Available from: https:\/\/www.nature.com\/articles\/s41596-021-00659-2. Cited 2023 Oct 16.","journal-title":"Nature Protocols"},{"issue":"7873","key":"3243_CR260","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","volume":"596","author":"J Jumper","year":"2021","unstructured":"Jumper J, Evans R, Pritzel A, Green T, Figurnov M, Ronneberger O, et al. Highly accurate protein structure prediction with AlphaFold. Nature. 2021;596(7873):583\u20139. Available from: https:\/\/www.nature.com\/articles\/s41586-021-03819-2. Cited 2023 Oct 16.","journal-title":"Nature"},{"issue":"8","key":"3243_CR261","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1038\/s41587-022-01618-2","volume":"41","author":"A Madani","year":"2023","unstructured":"Madani A, Krause B, Greene ER, Subramanian S, Mohr BP, Holton JM, et al. Large language models generate functional protein sequences across diverse families. Nat Biotechnolo. 2023;41(8):1099\u2013106. Available from: https:\/\/www.nature.com\/articles\/s41587-022-01618-2. Cited 2023 Oct 16.","journal-title":"Nat Biotechnolo"},{"issue":"6","key":"3243_CR262","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/s41551-022-00991-2","volume":"7","author":"J Huang","year":"2023","unstructured":"Huang J, Xu Y, Xue Y, Huang Y, Li X, Chen X, et al. Identification of potent antimicrobial peptides via a machine-learning pipeline that mines the entire space of peptide sequences. Nat Biomed Eng. 2023;7(6):797\u2013810. Available from: https:\/\/www.nature.com\/articles\/s41551-022-00991-2. Cited 2023 Oct 16.","journal-title":"Nat Biomed Eng"},{"issue":"1","key":"3243_CR263","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41551-021-00801-1","volume":"6","author":"MDT Torres","year":"2021","unstructured":"Torres MDT, Melo MCR, Crescenzi O, Notomista E, de la Fuente-Nunez C. Mining for encrypted peptide antibiotics in the human proteome. Nat Biomed Eng. 2021;6(1):67\u201375. Available from: https:\/\/www.nature.com\/articles\/s41551-021-00801-1. Cited 2023 Oct 16.","journal-title":"Nat Biomed Eng"},{"key":"3243_CR264","doi-asserted-by":"crossref","unstructured":"Fjell CD, Jenssen H, Hilpert K, Cheung WA, Pant\u00e9 N, Robert \u22a5, et al. Identification of Novel Antibacterial Peptides by Chemoinformatics and Machine Learning \u2020. 2008.","DOI":"10.1021\/jm8015365"}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-024-03243-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12866-024-03243-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-024-03243-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T02:03:01Z","timestamp":1711591381000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmicrobiol.biomedcentral.com\/articles\/10.1186\/s12866-024-03243-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,28]]},"references-count":264,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3243"],"URL":"https:\/\/doi.org\/10.1186\/s12866-024-03243-2","relation":{},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,28]]},"assertion":[{"value":"8 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"103"}}